Samuel So, MD

Surgical oncologist, Liver surgeon, General surgeon

Lui Hac Minh Professor in the School of Medicine

View Professional Summary

Additional Languages Spoken:

Cantonese

Insurance Coverage

Resources for Referring Physicians

Biography

Dr. Samuel So is the Lui Hac Minh Professor and Professor of Surgery. He is also the founder of the multidisciplinary liver cancer program at the Stanford Cancer Center, and the founder and executive director of the Asian Liver Center at Stanford University School of Medicine. Dr. So is a native of Hong Kong and received his surgical training at the University of Hong Kong and the University of Minnesota where he also completed his fellowship in multi-organ transplantation. His current clinical area of specialty is multidisciplinary approach in the treatment of primary liver cancer and management of chronic hepatitis B infection. He is listed among the Best Doctors in America.

Dr. So is recognized worldwide for his expertise in chronic hepatitis B and primary liver cancer prevention, research, treatment and health policy. He served as a consultant for the FDA and was a member and co-chair of the U.S. Department of Health and Human Services Office of Minority Health’s Hepatitis B Expert Panel. He was also a member of the Board of Population Health and Public Health Practices of the Institute of Medicine of the National Academies, and a committee member of the 2010 IOM report on “Hepatitis and Liver Cancer: a national strategy for the prevention and control of hepatitis B and C”, and the 2016 National Academy of Sciences, Engineering and Medicine report on “Eliminating the Public Health Problem of Hepatitis B and C in the United States. He also serves as a special adviser on viral hepatitis for the World Health Organization Western Pacific regional office. In 2010, he received the CDC and ATSDR Honor Award for mobilizing people and resources in ways that have changed global public health policies related to hepatitis B, and was recognized in 2014 by the White House for global and national leadership in the prevention and control of viral hepatitis.

View Full Biography

Professional Summary

Education & Certifications

Fellowship: University of Minnesota School of Medicine (1989) MN
Board certification, American Board of Surgery, General Surgery (1990)
Fellowship, University of Minnesota, Minneapolis, MN, Multi-organ Transplantation (1989)
- Medical Education: University of Hong Kong (1978) China
- M.B., B.S., University of Hong Kong, Medicine and Surgery (1978)
- B.A., summa cum laude, University of Minnesota, Minneapolis, MN, Microbiology (1973)

View More Education & Certifications

Honors & Awards

10th Annual Salute to Excellence Award, American Liver Foundation (2008)
12th Outstanding World Chinese Award, World Chinese Business Foundation, Hong Kong (2010)
2005 National Leadership Award, New York University Center for the Study of Asian American Health (2005)
- 34th Annual Award, Chinese Hospital, San Francisco (2007)
- Ally Award, Asian and Pacific Islander Wellness Center, San Francisco (2003)
- Angel in Medicine, Angels in Medicine (2008)
- Asia Game Changer West Award, Asian Society Northern California (2019)
- Asian American Achievement Award, Organization of Chinese Americans, San Mateo, California (2010)
- Asian and Pacific Heritage Award for Excellence in Science, California Asian Pacific Islander Joint Legislative Caucus (2009)
- Best Doctors in America, Woodard/White Compendium (1998-present)
- Best Doctors in San Francisco, San Francisco Magazine (1998-present)
- Best Doctors in Silicon Valley (Surgery), San Jose Magazine (1998-present)
- Center for Asian Health Research and education Award, Stanford Medicine (2019)
- Christopher NH Jenkins Cancer Control Award, Asian American Network for Cancer Awareness, Research and Training (2015)
- Commendation for outreach and increasing awareness about hepatitis B and liver cancer prevention, City and County of San Francisco (2002)
- Commendation for Public Service, City of Milpitas, CA (2001)
- Community Hero Award, World Journal Chinese Newspaper (2004)
- Distinguished Advocacy Service Award, American Association for the Study of Liver Diseases (2023)
- Distinguished Asian Leadership Award, Asian Business League of San Francisco (2001)
- Distinguished Physician Award, Chinese American Physicians Society (2000)
- Excellence in Partnering Award-Domestic, National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention (2010)
- Fervent Global Love of Lives Award, Chou-Ta Kuan Cultural and Education Foundation, Taiwan (2008)
- Honor Award for Excellence in Partnering in Global Health, CDC and ATSDR (2010)
- Jade Ribbon HBV Outstanding Contribution Award, Second National Workshop of Chinese HBV Carriers' Community, China (2009)
- Local Hero of the Year Award, KQED Public Radio and Television, San Francisco (2004)
- Outstanding American by Choice Award, US Citizenship and Immigration Services (2010)
- Outstanding Individual of the Year, Asian American Women Alliance, Santa Clara, California (2011)
- Profile of Excellence Award, ABC 7 Television, San Francisco (2004)
- Ron Smith Legacy Award, SF Hep B Free - Bay Area (2018)
- Ronald P Bangasser MD, Immunization Leadership Award, California Immunization Coalition (2014)
- Santiago Ramon y Cajal Award for Outstanding Research in Minority Health, National Minority Health Month, Washington, DC (2003)
- Stanford University Asian Faculty Award, Stanford University (2003)
- Star Award for Community Service, Asian Americans for Community Involvement, San Jose (2007)
- White House award in recognition of leadership in prevention and treatment of viral hepatitis, The White House, Washington DC (2014)
- Who's Who in America, Marquis Who's Who LLC. (2003-present)
- Who's Who in Science and Technology, Marquis Who's Who LLC. (2005-present)
- Who's Who in the World, Who's Who in Medicine and Healthcare, Marquis Who's Who LCC (2006-present)

View More Honors & Awards

Memberships

Advisory Committee member, WHO Western Pacific Region Viral Hepatitis Strategic and Technical Advisory Committee (2015 - Present)
Executive Board, Coalition for Global Hepatitis Elimination (2019 - Present)
Advisory Committee member, CDC/HRSA Advisory Committee on HIV, Viral Hepatitis, STD Prevention and Treatment (2021 - Present)

Administrative Appointments

Affiliate member, Bio-X (2016 - Present)
Appointments and Promotion Committee, Stanford University School of Medicine (2004 - 2007)
Appointments and Promotion Committee, Stanford University School of Medicine (2007 - 2010)
- Board on Population Health and Public Health Practice, Institute of Medicine of the National Academies (2006 - 2012)
- CHACHSPT Member, CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHACHSPT) (2021 - 2024)
- Chair, National Task Force on Hepatitis B: Focus on Asian & Pacific Islander Americans (2004 - 2010)
- Chair, Cancer Site Team, American Cancer Society, California Division (2003 - 2005)
- Civil Society Reference Group on Hepatitis, World Health Organization, Geneva (2014 - Present)
- Co-Chairman and co-founder, Scientific Advisory Board, Studies in Pediatric Liver Transplantation (1995 - 2001)
- Committee on a National Strategy for the Elimination of Hepatitis B & C, The National Academies of Sciences, Engineering and Medicine (2015 - 2017)
- Committee on the Prevention and Control of Viral Hepatitis in the United States, Institute of Medicine of the National Academies (2008 - 2010)
- Conflict of Interest Committee, Stanford University School of Medicine (2008 - Present)
- Consultant, Center for Drug Evaluation and Research, FDA, DHHS (1999 - 2013)
- Consultant, Centers for Disease Control and Prevention (2005 - Present)
- Fellow, Stanford Center for Innovation in Global Health (2015 - Present)
- Founder and Director , Multidisciplinary Liver Cancer Program, Stanford University Medical Center (1998 - Present)
- Founder and Director, Asian Liver Center, Stanford University (1996 - Present)
- Hepatitis Expert Resource Panel, World Health Organization Western Pacific Region (2013 - Present)
- Informatics and Data Committee, American Society of Transplant Surgeons (1997 - 2000)
- Liver and Intra-Abdominal Organs Committee, American Society of Transplant Physicians (1995 - 1999)
- Lui Hac Minh Professor, Stanford University School of Medicine (2003 - Present)
- Member, Stanford Center for Population Health Sciences (2015 - Present)
- Member in Population Sciences, Stanford Cancer Institute (2003 - Present)
- Member of the Board, American Cancer Society, California Division (2002 - 2006)
- Member of the National Assembly, American Cancer Society (2003 - 2005)
- Member of the Scientific Advisory Board, Studies in Pediatric Liver Transplantation (1995 - Present)
- Pediatric Committee, United Network of Organ Sharing (1989 - 1992)
- Pediatric Committee, American Society of Transplant Physicians (1993 - 1995)
- Roundtable on Health Disparity, Institute of Medicine of the National Academies (2008 - 2012)
- Scientific Studies Committee, American Society of Transplantation (1997 - 2000)
- Special Adviser on Viral Hepatitis, World Health Organization Western Pacific Region (2011 - Present)
- Strategic Technical Advisory Committee for Viral Hepatitis in the Western Pacific, World Health Organization Western Pacific Region (2015 - Present)

View More Administrative Appointments

Publications

Indications for pediatric liver transplantation.
McDiarmid, S. V., Millis, M. J., Olthoff, K. M., & So, S. K. (1998). Indications for pediatric liver transplantation. Pediatric Transplantation, 2(2), 106–116.
Current status of living-related liver transplantation.
Hayashi, M., Cao, S., Concepcion, W., Monge, H., Ojogho, O., So, S., & Esquivel, C. O. (1998). Current status of living-related liver transplantation. Pediatric Transplantation, 2(1), 16–25.
Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus.
Cao, S., Cox, K. L., Berquist, W., Hayashi, M., Concepcion, W., Hammes, G. B., … Esquivel, C. O. (1999). Long-term outcomes in pediatric liver recipients: comparison between cyclosporin A and tacrolimus. Pediatric Transplantation, 3(1), 22–26.
- Major hepatic resection without blood transfusion: Experience with total vascular exclusion
  So, S. K., Monge, H., & Esquivel, C. O. (1999). Major hepatic resection without blood transfusion: Experience with total vascular exclusion. Presented at the 1st University-of-California-San-Francisco/Stanford Asia Liver Symposium, HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG: WILEY-BLACKWELL PUBLISHING, INC.
- Resection versus transplantation for hepatocellular carcinoma
  Esquivel, C. O., Keeffe, E. B., Garcia, G., Imperial, J. C., Millan, M. T., Monge, H., & So, S. K. (1999). Resection versus transplantation for hepatocellular carcinoma. Presented at the 1st University-of-California-San-Francisco/Stanford Asia Liver Symposium, HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG: WILEY-BLACKWELL PUBLISHING, INC.
- Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis?
  So, S. K., Esquivel, C. O., Imperial, J. C., Garcia, G., Monge, H., & Keeffe, E. B. (1999). Does Asian race affect hepatitis B virus recurrence or survival following liver transplantation for hepatitis B cirrhosis? Presented at the 1st University-of-California-San-Francisco/Stanford Asia Liver Symposium, HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG,HONG KONG: WILEY-BLACKWELL PUBLISHING, INC.
- Liver transplantation at Stanford University Medical Center.
  Millan, M. T., Keeffe, E. B., Berquist, W. E., Castillo, R. O., Cox, K. L., Garcia, G., … Esquivel, C. O. (1998). Liver transplantation at Stanford University Medical Center. Clinical Transplants, 287–96.
- Intravenous ribavirin therapy for adenovirus pneumonia
  Shetty, A. K., Gans, H. A., So, S., Millan, M. T., Arvin, A. M., & Gutierrez, K. M. (2000). Intravenous ribavirin therapy for adenovirus pneumonia. PEDIATRIC PULMONOLOGY, 29(1), 69–73.
- Significance of detecting Epstein-Barr-Specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients
  Krieger, N. R., Martinez, O. M., Krams, S. M., Cox, K., So, S., & Esquivel, C. O. (2000). Significance of detecting Epstein-Barr-Specific sequences in the peripheral blood of asymptomatic pediatric liver transplant recipients. LIVER TRANSPLANTATION, 6(1), 62–66.
- A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts
  Millan, M. T., Sarwal, M. M., Lemley, K. V., Yorgin, P., Orlandi, P., So, S., … Salvatierra, O. (2000). A 100% 2-year graft survival can be attained in high-risk 15-kg or smaller infant recipients of kidney allografts. ARCHIVES OF SURGERY. SAN FRANCISCO,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA,CALIFORNIA: AMER MEDICAL ASSOC.
- CMV and EBV-PTLD after liver transplantation
  So, S. (2001). CMV and EBV-PTLD after liver transplantation. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1317–19.
- Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis
  Lai, K. M., MILLAN, M., Razavi, M., Keeffe, E. B., Prapong, W., Fisher, G. A., … So, S. K. S. (2001). Center experience in liver transplantation for hepatocellular carcinoma associated with cirrhosis. TRANSPLANTATION PROCEEDINGS, 33(1-2), 1490–91.
- Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma
  Sze, D. Y., Razavi, M. K., So, S. K. S., & Jeffrey, R. B. (2001). Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma. AMERICAN JOURNAL OF ROENTGENOLOGY, 177(6), 1339–45.
- Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts
  Millan, M. T., Natkunam, Y., Clarke-Katzenberg, R., Desai, D., Prapong, W., So, S. K., … Martinez, O. M. (2002). Epstein-Barr virus infection is associated with endothelial bcl-2 expression in transplant liver allografts. TRANSPLANTATION, 73(3), 465–69.
- Gene expression patterns in human liver cancers
  Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., Higgins, J., … Brown, P. O. (2002). Gene expression patterns in human liver cancers. MOLECULAR BIOLOGY OF THE CELL, 13(6), 1929–39.
- Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor
  Cheung, S. T., Chen, X., GUAN, X. Y., Wong, S. Y., Tai, L. S., Ng, I. O. L., … Fan, S. T. (2002). Identify metastasis-associated genes in hepatocellular carcinoma through clonality delineation for multinodular tumor. CANCER RESEARCH, 62(16), 4711–21.
- Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines
  Ji, J. F., Chen, X., Leung, S. Y., Chi, J. T. A., Chu, K. M., Yuen, S. T., … So, S. (2002). Comprehensive analysis of the gene expression profiles in human gastric cancer cell lines. ONCOGENE, 21(42), 6549–56.
- Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis
  Leung, S. Y., Chen, X., Chu, K. M., Yuen, S. T., Mathy, J., Ji, J. F., … Brown, P. O. (2002). Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 99(25), 16203–8.
- Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion.
  Kim, P., Prapong, W., Sze, D. Y., So, S. K., & Razavi, M. K. (2002). Treatment of hepatocellular carcinoma with sub-selective transcatheter arterial oily chemoinfusion. Techniques in Vascular and Interventional Radiology, 5(3), 127–31.
- Variation in gene expression patterns in human gastric cancers
  Chen, X., Leung, S. Y., Yuen, S. T., Chu, K. M., Ji, J. F., Li, R., … Brown, P. O. (2003). Variation in gene expression patterns in human gastric cancers. MOLECULAR BIOLOGY OF THE CELL, 14(8), 3208–15.
- QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506
  Johnson, M. C., So, S., Marsh, J. W., & Murphy, A. M. (1992). QT PROLONGATION AND TORSADES-DE-POINTES AFTER ADMINISTRATION OF FK506. TRANSPLANTATION, 53(4), 929–930.
- FK506 - INHIBITION OF HUMORAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION
  Woodle, E. S., Perdrizet, G. A., Brunt, E. M., So, S. K. S., Jendrisak, M. D., McCullough, C. S., … Marsh, J. W. (1992). FK506 - INHIBITION OF HUMORAL MECHANISMS OF HEPATIC ALLOGRAFT-REJECTION. TRANSPLANTATION, 54(2), 377–381.
- Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma
  Chan, A. S. W., Tsui, W. Y., Chen, X., Chu, K. M., Chan, T. L., Chan, A. S. Y., … Leung, S. Y. (2003). Downregulation of ID4 by promoter hypermethylation in gastric adenocarcinoma. ONCOGENE, 22(44), 6946–53.
- One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience
  Millan, M. T., Berquist, W. E., So, S. K., Sarwal, M. M., Wayman, K. I., Cox, K. L., … Esquivel, C. O. (2003). One hundred percent patient and kidney allograft survival with simultaneous liver and kidney transplantation in infants with primary hyperoxaluria: A single-center experience. TRANSPLANTATION, 76(10), 1458–63.
- Novel endothelial cell markers in hepatocellular carcinoma
  Chen, X., Higgins, J., Cheung, S. T., Li, R., Mason, V., Montgomery, K., … So, S. (2004). Novel endothelial cell markers in hepatocellular carcinoma. MODERN PATHOLOGY, 17(10), 1198–1210.
- Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer
  Leung, S. Y., Yuen, S. T., Chu, K. M., Mathy, J. A., Li, R., Chan, A. S. Y., … So, S. (2004). Expression profiling identifies chemokine (C-C motif) ligand 18 as an independent prognostic indicator in gastric cancer. GASTROENTEROLOGY, 127(2), 457–69.
- EARLY OCCURRENCE OF END-STAGE RENAL-DISEASE IN A PATIENT WITH INFANTILE NEPHROPATHIC CYSTINOSIS
  Schnaper, H. W., COTTEL, J., Merrill, S., Marcusson, E., Kissane, J. M., Shackelford, G. D., … Schneider, J. A. (1992). EARLY OCCURRENCE OF END-STAGE RENAL-DISEASE IN A PATIENT WITH INFANTILE NEPHROPATHIC CYSTINOSIS. JOURNAL OF PEDIATRICS, 120(4), 575–578.
- Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma
  Lin, A. Y., Brophy, N., Fisher, G. A., So, S., Biggs, C., Yock, T. I., & Levitt, L. (2005). Phase II study of thalidomide in patients with unresectable hepatocellular carcinoma. CANCER, 103(1), 119–25.
- Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma
  Cheung, S. T., Wong, S. Y., Leung, K. L., Chen, X., So, S., Ng, I. O., & Fan, S. T. (2004). Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma. CLINICAL CANCER RESEARCH, 10(22), 7629–36.
- Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma
  Cheung, S. T., Leung, K. L., Ip, Y. C., Chen, X., FONG, D. Y., Ng, I. O., … So, S. (2005). Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. CLINICAL CANCER RESEARCH, 11(2), 551–56.
- An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma
  Patil, M. A., Chua, M. S., Pan, K. H., Lin, R., Lih, C. J., Cheung, S. T., … So, S. (2005). An integrated data analysis approach to characterize genes highly expressed in hepatocellular carcinoma. ONCOGENE, 24(23), 3737–47.
- Mutations of PIK3CA in gastric adenocarcinoma
  Li, V. S. W., Wong, C. W., Chan, T. L., Chan, A. S. W., Zhao, W., Chu, K. M., … Leung, S. Y. (2005). Mutations of PIK3CA in gastric adenocarcinoma. BMC CANCER, 5.
- Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy
  Cheung, S. T., Ho, J. C. Y., Leung, K. L., Chen, X., Fong, D. Y. T., So, S., & Fan, S. T. (2005). Transcript AA454543 is a novel prognostic marker for hepatocellular carcinoma after curative partial hepatectomy. NEOPLASIA, 7(2), 91–98.
- Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma
  Patil, M. A., Gutgemann, I., Zhang, J., Ho, C., Cheung, S. T., Ginzinger, D., … Chen, X. (2005). Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. CARCINOGENESIS, 26(12), 2050–57.
- Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment
  Hsu, C. P., Razavi, M. K., So, S. K., Parachikov, I. H., & Benaron, D. A. (2005). Liver tumor gross margin identification and ablation monitoring during liver radiofrequency treatment. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY, 16(11), 1473–1478.
- Topological and functional discovery in a gene coexpression meta-network of gastric cancer
  Aggarwal, A., Guo, D. L., Hoshida, Y., Yuen, S. T., Chu, K. M., So, S., … Tan, P. (2006). Topological and functional discovery in a gene coexpression meta-network of gastric cancer. CANCER RESEARCH, 66(1), 232–41.
- Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma
  Fong, C. W., Chua, M. S., McKie, A. B., Ling, S. H. M., Mason, L., Li, R., … Guy, G. R. (2006). Sprouty 2, an inhibitor of mitogen-activated protein kinase signaling, is down-regulated in hepatocellular carcinoma. CANCER RESEARCH, 66(4), 2048–58.
- Comprehensive analysis of 19q12 amplicon in human gastric cancers
  Leung, S. Y., Ho, C., Tu, I.-P., Li, R., So, S., Chu, K.-M., … Chen, X. (2006). Comprehensive analysis of 19q12 amplicon in human gastric cancers. MODERN PATHOLOGY, 19(6), 854–63.
- Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma
  Chua, M.-S., Bernstein, L. R., Li, R., & So, S. K. S. (2006). Gallium maltolate is a promising chemotherapeutic agent for the treatment of hepatocellular carcinoma. ANTICANCER RESEARCH, 26(3A), 1739–43.
- Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma
  Chua, M.-S., Sun, H., Cheung, S. T., Mason, V., Higgins, J., Ross, D. T., … So, S. (2007). Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma. MODERN PATHOLOGY, 20(1), 76–83.
- FK-506 - REVERSAL OF HUMORALLY MEDIATED REJECTION FOLLOWING ABO-INCOMPATIBLE LIVER-TRANSPLANTATION
  Woodle, E. S., Perdrizet, G. A., Brunt, E. M., So, S. K. S., Jendrisak, M. D., McCullough, C. S., … Marsh, J. W. (1991). FK-506 - REVERSAL OF HUMORALLY MEDIATED REJECTION FOLLOWING ABO-INCOMPATIBLE LIVER-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(6), 2992–2993.
- The burden of liver cancer in Asians and Pacific Islanders in the greater San Francisco Bay Area, 1990 through 2004
  Chang, E. T., Keegan, T. H. M., Gomez, S. L., Le, G. M., Clarke, C. A., So, S. K. S., & Glaser, S. L. (2007). The burden of liver cancer in Asians and Pacific Islanders in the greater San Francisco Bay Area, 1990 through 2004. CANCER, 109(10), 2100–2108.
- Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California
  Wu, C. A., Lin, S. Y., So, S. K., & Chang, E. T. (2007). Hepatitis B and liver cancer knowledge and preventive practices among Asian Americans in the San Francisco Bay Area, California. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 8(1), 127–34.
- Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California
  Lin, S. Y., Chang, E. T., & So, S. K. (2007). Why we should routinely screen Asian American adults for hepatitis B: A cross-sectional study of Asians in California. HEPATOLOGY, 46(4), 1034–40.
- Re: "Ten largest racial and ethnic health disparities in the United States based on healthy people 2010 objectives"
  Chang, E. T., & So, S. K. S. (2007). Re: "Ten largest racial and ethnic health disparities in the United States based on healthy people 2010 objectives". AMERICAN JOURNAL OF EPIDEMIOLOGY, 166(9), 1105–1106.
- Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B
  Hutton, D. W., Tan, D., So, S. K., & Brandeau, M. L. (2007). Cost-effectiveness of screening and vaccinating Asian and pacific islander adults for hepatitis B. ANNALS OF INTERNAL MEDICINE, 147(7), 460–69.
- The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans
  Chao, S. D., Chang, E. T., Le, P. V., Prapong, W., Kiernan, M., & So, S. K. S. (2009). The Jade Ribbon Campaign: A Model Program for Community Outreach and Education to Prevent Liver Cancer in Asian Americans. JOURNAL OF IMMIGRANT AND MINORITY HEALTH, 11(4), 281–90.
- Building partnerships with Traditional Chinese Medicine Practitioners to increase hepatitis B awareness and prevention
  Chang, E. T., Lin, S. Y., Sue, E., Bergin, M., Su, J., & So, S. K. S. (2007). Building partnerships with Traditional Chinese Medicine Practitioners to increase hepatitis B awareness and prevention. JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE, 13(10), 1125–27.
- N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells
  Yan, X., Chua, M.-S., Sun, H., & So, S. (2008). N-Myc down-regulated gene 1 mediates proliferation, invasion, and apoptosis of hepatocellular carcinoma cells. CANCER LETTERS, 262(1), 133–42.
- Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo
  Yan, X., Chua, M.-S., He, J., & So, S. K. (2008). Small interfering RNA targeting CDC25B inhibits liver tumor growth in vitro and in vivo. MOLECULAR CANCER, 7.
- Phase H study of imatinib in unresectable hepatocellular carcinoma
  Lin, A. Y., Fisher, G. A., So, S., Tang, C., & Levitt, L. (2008). Phase H study of imatinib in unresectable hepatocellular carcinoma. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 31(1), 84–88.
- A PROSPECTIVE RANDOMIZED COMPARISON OF PROPHYLACTIC ALG AND OKT3 IN CADAVER KIDNEY ALLOGRAFT RECIPIENTS
  Hanto, D. W., Jendrisak, M. D., McCullough, C. S., So, S. K. S., Marsh, J. W., Rush, T., … Mohanakumar, T. (1991). A PROSPECTIVE RANDOMIZED COMPARISON OF PROPHYLACTIC ALG AND OKT3 IN CADAVER KIDNEY ALLOGRAFT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 23(1), 1050–1051.
- 3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian and Pacific Islander Americans
  Chang, E. T., Sue, E., Zola, J., & So, S. K. (2009). 3 For Life: A Model Pilot Program to Prevent Hepatitis B Virus Infection and Liver Cancer in Asian and Pacific Islander Americans. AMERICAN JOURNAL OF HEALTH PROMOTION, 23(3), 176–81.
- Attitudes toward Hepatitis B and Liver Cancer Prevention among Chinese Americans in the San Francisco Bay Area, California
  Chang, E. T., Nguyen, B. H., & So, S. K. S. (2008). Attitudes toward Hepatitis B and Liver Cancer Prevention among Chinese Americans in the San Francisco Bay Area, California. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 9(4), 605–613.
- Frequent Inactivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic and Epigenetic Mechanisms
  Li, V. S. W., Yuen, S. T., Chan, T. L., Yan, H. H. N., Law, W. L., Yeung, B. H. Y., … Leung, S. Y. (2009). Frequent Inactivation of Axon Guidance Molecule RGMA in Human Colon Cancer Through Genetic and Epigenetic Mechanisms. GASTROENTEROLOGY, 137(1), 176–87.
- RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS-ERYTHEMATOSUS AND RECURRENT LUPUS NEPHRITIS - A SINGLE-CENTER EXPERIENCE AND A REVIEW OF THE LITERATURE
  Goss, J. A., Cole, B. R., Jendrisak, M. D., McCullough, C. S., So, S. K. S., Windus, D. W., & Hanto, D. W. (1991). RENAL-TRANSPLANTATION FOR SYSTEMIC LUPUS-ERYTHEMATOSUS AND RECURRENT LUPUS NEPHRITIS - A SINGLE-CENTER EXPERIENCE AND A REVIEW OF THE LITERATURE. TRANSPLANTATION, 52(5), 805–810.
- ANESTHETIC MANAGEMENT OF INFANTS RECEIVING AN ADULT KIDNEY-TRANSPLANT
  Beebe, D. S., Belani, K. G., MERGENS, P., Liao, J. C., So, S. K. S., Najarian, J. S., & PALAHNIUK, R. J. (1991). ANESTHETIC MANAGEMENT OF INFANTS RECEIVING AN ADULT KIDNEY-TRANSPLANT. ANESTHESIA AND ANALGESIA, 73(6), 725–730.
- Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma.
  Sun, H., Chua, M.-S., Yang, D., Tsalenko, A., Peter, B. J., & So, S. (2008). Antibody Arrays Identify Potential Diagnostic Markers of Hepatocellular Carcinoma. Biomarker Insights, 3, 1–18.
- Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community: A Chronic Hepatitis B and Liver Cancer Prevention Clinic by Medical Students
  Lin, S. Y., Chang, E. T., & So, S. K. (2009). Stopping a Silent Killer in the Underserved Asian and Pacific Islander Community: A Chronic Hepatitis B and Liver Cancer Prevention Clinic by Medical Students. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 10(3), 383–86.
- Eliminating the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community: A Call to Action
  Chao, S. D., Chang, E. T., & So, S. K. (2009). Eliminating the Threat of Chronic Hepatitis B in the Asian and Pacific Islander Community: A Call to Action. ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 10(3), 507–12.
- Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo
  Wei, W., Chua, M.-S., Grepper, S., & So, S. (2010). Small molecule antagonists of Tcf4/beta-catenin complex inhibit the growth of HCC cells in vitro and in vivo. INTERNATIONAL JOURNAL OF CANCER, 126(10), 2426–36.
- Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells
  Wei, W., Chua, M.-S., Grepper, S., & So, S. K. (2009). Blockade of Wnt-1 signaling leads to anti-tumor effects in hepatocellular carcinoma cells. MOLECULAR CANCER, 8.
- Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China
  Hutton, D. W., So, S. K., & Brandeau, M. L. (2010). Cost-Effectiveness of Nationwide Hepatitis B Catch-up Vaccination Among Children and Adolescents in China. HEPATOLOGY, 51(2), 405–14.
- Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma
  Yen, Y., So, S., Rose, M., Saif, M. W., Chu, E., Liu, S.-H., … Cheng, Y.-C. (2009). Phase I/II Study of PHY906/Capecitabine in Advanced Hepatocellular Carcinoma. ANTICANCER RESEARCH, 29(10), 4083–92.
- SUCCESSFUL KIDNEY-TRANSPLANTATION IN INFANTS
  Najarian, J. S., Frey, D. J., Matas, A. J., So, S. K. S., Cook, M., Mauer, S. M., … Nevins, T. E. (1991). SUCCESSFUL KIDNEY-TRANSPLANTATION IN INFANTS. TRANSPLANTATION PROCEEDINGS, 23(1), 1382–1383.
- SHORT-TERM AND LONG-TERM EFFECTS OF HLA MATCHING IN CADAVERIC PANCREAS TRANSPLANTATION
  So, S. K. S., MOUDRYMUNNS, K. C., Gillingham, K., Minford, E. J., & Sutherland, D. E. R. (1991). SHORT-TERM AND LONG-TERM EFFECTS OF HLA MATCHING IN CADAVERIC PANCREAS TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 1634–1636.
- SIGNIFICANCE OF B-CELL CROSS-MATCH ON OUTCOME IN RENAL-TRANSPLANTATION
  Jendrisak, M., Phelan, D., Marsh, J., McCullough, C., So, S., Mohanakumar, T., … Hanto, D. (1991). SIGNIFICANCE OF B-CELL CROSS-MATCH ON OUTCOME IN RENAL-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 23(1), 434–436.
- LAPAROSCOPIC DRAINAGE OF A POSTTRANSPLANT LYMPHOCELE
  McCullough, C. S., Soper, N. J., Clayman, R. V., So, S. S. K., Jendrisak, M. D., & Hanto, D. W. (1991). LAPAROSCOPIC DRAINAGE OF A POSTTRANSPLANT LYMPHOCELE. TRANSPLANTATION, 51(3), 725–727.
- Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study
  Chao, J., Chang, E. T., & So, S. K. S. (2010). Hepatitis B and liver cancer knowledge and practices among healthcare and public health professionals in China: a cross-sectional study. BMC PUBLIC HEALTH, 10.
- Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease
  El-Serag, H., McGlynn, K. A., Graham, G. N., So, S., Howell, C. D., Fang, T., … Thiel, T. K. (2010). Achieving health equity to eliminate racial, ethnic, and socioeconomic disparities in HBV- and HCV-associated liver disease. JOURNAL OF FAMILY PRACTICE, 59(4), S37–S42.
- Disparities in Liver Cancer Incidence by Nativity, Acculturation, and Socioeconomic Status in California Hispanics and Asians
  Chang, E. T., Yang, J., Alfaro-Velcamp, T., So, S. K. S., Glaser, S. L., & Gomez, S. L. (2010). Disparities in Liver Cancer Incidence by Nativity, Acculturation, and Socioeconomic Status in California Hispanics and Asians. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 19(12), 3106–3118.
- San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer
  Bailey, M. B., Shiau, R., Zola, J., Fernyak, S. E., Fang, T., So, S. K. S., & Chang, E. T. (2011). San Francisco Hep B Free: A Grassroots Community Coalition to Prevent Hepatitis B and Liver Cancer. JOURNAL OF COMMUNITY HEALTH, 36(4), 538–51.
- Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin
  Wei, W., Chua, M.-S., Grepper, S., & So, S. K. (2011). Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. MOLECULAR CANCER, 10.
- Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker
  Lin, A. Y., Chua, M.-S., Choi, Y.-L., Yeh, W., Kim, Y. H., Azzi, R., … Pollack, J. R. (2011). Comparative Profiling of Primary Colorectal Carcinomas and Liver Metastases Identifies LEF1 as a Prognostic Biomarker. PLOS ONE, 6(2).
- REVERSIBLE HEPATIC TRANSPLANT ISCHEMIA - CASE-REPORT AND REVIEW OF LITERATURE
  Castaneda, F., So, S. K. S., Hunter, D. W., CASTANEDAZUNIGA, W. R., & Amplatz, K. (1990). REVERSIBLE HEPATIC TRANSPLANT ISCHEMIA - CASE-REPORT AND REVIEW OF LITERATURE. CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, 13(2), 88–90.
- In vivo MRSI of hyperpolarized [1-C-13]pyruvate metabolism in rat hepatocellular carcinoma
  Darpolor, M. M., Yen, Y.-F., Chua, M.-S., Xing, L., Clarke-Katzenberg, R. H., Shi, W., … Spielman, D. M. (2011). In vivo MRSI of hyperpolarized [1-C-13]pyruvate metabolism in rat hepatocellular carcinoma. NMR IN BIOMEDICINE, 24(5), 506–13.
- Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions
  Hutton, D. W., Brandeau, M. L., & So, S. K. (2011). Doing Good with Good OR: Supporting Cost-Effective Hepatitis B Interventions. INTERFACES, 41(3), 289–300.
- A model program for hepatitis B vaccination and education of schoolchildren in rural China
  Chen, J. J., Chang, E. T., Chen, Y.-ren, Bailey, M. B., & So, S. K. S. (2012). A model program for hepatitis B vaccination and education of schoolchildren in rural China. INTERNATIONAL JOURNAL OF PUBLIC HEALTH, 57(3), 581–88.
- Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-beta 2
  Sun, C. K., Chua, M.-S., He, J., & So, S. K. (2011). Suppression of Glypican 3 Inhibits Growth of Hepatocellular Carcinoma Cells through Up-Regulation of TGF-beta 2. NEOPLASIA, 13(8), 735–U111.
- The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors
  Willingham, S. B., Volkmer, J.-P., Gentles, A. J., Sahoo, D., Dalerba, P., Mitra, S. S., … Weissman, I. L. (2012). The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 109(17), 6662–67.
- THE USE OF CADAVER KIDNEYS FOR TRANSPLANTATION IN YOUNG-CHILDREN
  So, S. K. S., Gillingham, K., Cook, M., Mauer, S. M., Matas, A., Nevins, T. E., … Najarian, J. S. (1990). THE USE OF CADAVER KIDNEYS FOR TRANSPLANTATION IN YOUNG-CHILDREN. TRANSPLANTATION, 50(6), 979–983.
- Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma
  Bu, L., Xie, J., Chen, K., Huang, J., Aguilar, Z. P., Wang, A., … Chen, X. (2012). Assessment and comparison of magnetic nanoparticles as MRI contrast agents in a rodent model of human hepatocellular carcinoma. CONTRAST MEDIA & MOLECULAR IMAGING, 7(4), 363–72.
- Low Levels of Knowledge and Preventive Practices Regarding Vertical Hepatitis B Transmission among Perinatal Nurses
  Chao, S. D., Cheung, C. M., Yang, E. J., So, S. K. S., & Chang, E. T. (2012). Low Levels of Knowledge and Preventive Practices Regarding Vertical Hepatitis B Transmission among Perinatal Nurses. JOGNN-JOURNAL OF OBSTETRIC GYNECOLOGIC AND NEONATAL NURSING, 41(4), 494–505.
- DR MATCHING IMPROVES CADAVERIC PANCREAS TRANSPLANT RESULTS
  So, S. K. S., Minford, E. J., MOUDRYMUNNS, K. C., Gillingham, K., & Sutherland, D. E. R. (1990). DR MATCHING IMPROVES CADAVERIC PANCREAS TRANSPLANT RESULTS. TRANSPLANTATION PROCEEDINGS, 22(2), 687–688.
- Education and counseling of pregnant patients with chronic hepatitis B: perspectives from obstetricians and perinatal nurses in santa clara county, california.
  Yang, E. J., Cheung, C. M., So, S. K. S., Chang, E. T., & Chao, S. D. (2013). Education and counseling of pregnant patients with chronic hepatitis B: perspectives from obstetricians and perinatal nurses in santa clara county, california. Asian Pacific Journal of Cancer Prevention , 14(3), 1707–13.
- Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes.
  Zhao, P., Yang, X., Qi, S., Liu, H., Jiang, H., Hoppmann, S., … Cheng, Z. (2013). Molecular imaging of hepatocellular carcinoma xenografts with epidermal growth factor receptor targeted affibody probes. BioMed Research International, 2013, 759057-?
- RENAL-TRANSPLANTATION IN INFANTS
  Najarian, J. S., Frey, D. J., Matas, A. J., Gillingham, K. J., So, S. S. K., Cook, M., … Nevins, T. E. (1990). RENAL-TRANSPLANTATION IN INFANTS. ANNALS OF SURGERY, 212(3), 353–367.
- AFFERENT AND EFFERENT PATHWAYS IN T-CELL RESPONSES TO MHC CLASS I+, II-HEPATOCYTES
  Bumgardner, G. L., Chen, S., Hoffman, R., Cahill, D. C., So, S. K., Platt, J., … Ascher, N. L. (1989). AFFERENT AND EFFERENT PATHWAYS IN T-CELL RESPONSES TO MHC CLASS I+, II-HEPATOCYTES. TRANSPLANTATION, 47(1), 163–170.
- INVITRO IMMUNOSUPPRESSIVE EFFECTS OF MURINE HEPATOCYTE CYTOSOL
  Bumgardner, G. L., Billiar, T., So, S. K., Chen, S., Dunn, G., Payne, W., & Ascher, N. L. (1989). INVITRO IMMUNOSUPPRESSIVE EFFECTS OF MURINE HEPATOCYTE CYTOSOL. TRANSPLANTATION PROCEEDINGS, 21(1), 1154–1155.
- DIALYSIS ACCESS - RADIOGRAPHIC EVALUATION AND MANAGEMENT
  Hunter, D. W., & So, S. K. (1987). DIALYSIS ACCESS - RADIOGRAPHIC EVALUATION AND MANAGEMENT. RADIOLOGIC CLINICS OF NORTH AMERICA, 25(2), 249–260.
- Renal transplantation at the University of Minnesota during the 1980s.
  FRYD, D. S., MIGLIORI, R., SIMMONS, R. L., Chavers, B., Dunn, D., Payne, W., … Mauer, S. M. (1987). Renal transplantation at the University of Minnesota during the 1980s. Clinical Transplants, 167–181.
- A COMPARISON OF 3 IMMUNOSUPPRESSIVE PROTOCOLS IN PATIENTS AGED OVER 50 YEARS
  FRYD, D. S., So, S. K. S., Kruse, L., Canafax, D. M., Sutherland, D. E. R., SIMMONS, R. L., & Najarian, J. S. (1987). A COMPARISON OF 3 IMMUNOSUPPRESSIVE PROTOCOLS IN PATIENTS AGED OVER 50 YEARS. TRANSPLANTATION PROCEEDINGS, 19(1), 1530–1531.
- 1ST KIDNEY-TRANSPLANTS IN CHILDREN 5 YEARS OF AGE OR YOUNGER
  Najarian, J. S., So, S. K. S., SIMMONS, R. L., Mauer, S. M., Nevins, T. E., Sutherland, D. E. R., … FRYD, D. S. (1987). 1ST KIDNEY-TRANSPLANTS IN CHILDREN 5 YEARS OF AGE OR YOUNGER. TRANSPLANTATION PROCEEDINGS, 19(1), 2111–2112.
- CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ARE INDUCED ON HEPATOCYTES IN REJECTING HUMAN-LIVER GRAFTS
  So, S. K. S., Snover, D. C., Ascher, N. L., & Platt, J. L. (1987). CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ARE INDUCED ON HEPATOCYTES IN REJECTING HUMAN-LIVER GRAFTS. TRANSPLANTATION PROCEEDINGS, 19(1), 2464–2465.
- PURIFIED HEPATOCYTES CAN STIMULATE ALLOSPECIFIC CYTOLYTIC LYMPHOCYTES-T IN A MIXED LYMPHOCYTE-HEPATOCYTE CULTURE
  So, S. K. S., Wilkes, L. M., Platt, J. L., Ascher, N. L., & SIMMONS, R. L. (1987). PURIFIED HEPATOCYTES CAN STIMULATE ALLOSPECIFIC CYTOLYTIC LYMPHOCYTES-T IN A MIXED LYMPHOCYTE-HEPATOCYTE CULTURE. TRANSPLANTATION PROCEEDINGS, 19(1), 251–252.
- MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGENS ON HEPATOCYTES IN HUMAN-LIVER GRAFTS
  Platt, J. L., Ascher, N. L., Snover, D. C., & So, S. K. S. (1987). MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGENS ON HEPATOCYTES IN HUMAN-LIVER GRAFTS. TRANSPLANTATION PROCEEDINGS, 19(4), 66–67.
- LOW-DOSE CYCLOSPORINE THERAPY COMBINED WITH STANDARD IMMUNOSUPPRESSION IN PEDIATRIC RENAL-TRANSPLANTATION
  So, S. K. S., Najarian, J. S., Nevins, T. E., FRYD, D. S., Knaak, M., Chavers, B., … SIMMONS, R. L. (1987). LOW-DOSE CYCLOSPORINE THERAPY COMBINED WITH STANDARD IMMUNOSUPPRESSION IN PEDIATRIC RENAL-TRANSPLANTATION. JOURNAL OF PEDIATRICS, 111(6), 1017–1021.
- PRELIMINARY-RESULTS OF LOW-DOSE CYCLOSPORINE-A IN PEDIATRIC RENAL-TRANSPLANTATION
  Nevins, T. E., Knaak, M., So, S. K. S., Chavers, B., Melvin, T., SIMMONS, R. L., … Najarian, J. S. (1986). PRELIMINARY-RESULTS OF LOW-DOSE CYCLOSPORINE-A IN PEDIATRIC RENAL-TRANSPLANTATION. INTERNATIONAL JOURNAL OF PEDIATRIC NEPHROLOGY, 7(2), 91–94.
- CURRENT RESULTS IN PEDIATRIC RENAL-TRANSPLANTATION AT THE UNIVERSITY-OF-MINNESOTA
  So, S. K. S., Mauer, S. M., Nevins, T. E., FRYD, D. S., Sutherland, D. E. R., Ascher, N. L., … Najarian, J. S. (1986). CURRENT RESULTS IN PEDIATRIC RENAL-TRANSPLANTATION AT THE UNIVERSITY-OF-MINNESOTA. KIDNEY INTERNATIONAL, S25–S30.
- THE OUTCOME OF 304 PRIMARY RENAL-TRANSPLANTS IN CHILDREN (1968-1985)
  Najarian, J. S., So, S. K. S., SIMMONS, R. L., FRYD, D. S., Nevins, T. E., Ascher, N. L., … Mauer, S. M. (1986). THE OUTCOME OF 304 PRIMARY RENAL-TRANSPLANTS IN CHILDREN (1968-1985). ANNALS OF SURGERY, 204(3), 246–258.
- INCREASED EXPRESSION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON HEPATOCYTES IN REJECTING HUMAN-LIVER ALLOGRAFTS
  So, S. K. S., Platt, J. L., Ascher, N. L., & Snover, D. C. (1987). INCREASED EXPRESSION OF CLASS-I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON HEPATOCYTES IN REJECTING HUMAN-LIVER ALLOGRAFTS. TRANSPLANTATION, 43(1), 79–85.
- GROWTH AND DEVELOPMENT IN INFANTS AFTER RENAL-TRANSPLANTATION
  So, S. K. S., Chang, P. N., Najarian, J. S., Mauer, S. M., SIMMONS, R. L., & Nevins, T. E. (1987). GROWTH AND DEVELOPMENT IN INFANTS AFTER RENAL-TRANSPLANTATION. JOURNAL OF PEDIATRICS, 110(3), 343–350.
- IMPROVED RESULTS OF MULTIPLE RENAL-TRANSPLANTATION IN CHILDREN
  So, S. K. S., SIMMONS, R. L., FRYD, D. S., Najarian, J. S., & Mauer, S. M. (1985). IMPROVED RESULTS OF MULTIPLE RENAL-TRANSPLANTATION IN CHILDREN. SURGERY, 98(4), 729–737.
- THROMBOSED SYNTHETIC HEMODIALYSIS ACCESS FISTULAS - FAILURE OF FIBRINOLYTIC THERAPY
  Young, A. T., Hunter, D. W., CASTANEDAZUNIGA, W. R., So, S. K. S., Mercado, S., Cardella, J. F., & Amplatz, K. (1985). THROMBOSED SYNTHETIC HEMODIALYSIS ACCESS FISTULAS - FAILURE OF FIBRINOLYTIC THERAPY. RADIOLOGY, 154(3), 639–642.
- COMBINED EFFECT OF RADIOTHERAPY AND NEURAMINIDASE-TREATED TUMOR-CELLS ON 3-METHYLCHOLANTHRENE-INDUCED FIBROSARCOMA
  So, S. K. S., Song, C. W., Rios, A., & SIMMONS, R. L. (1977). COMBINED EFFECT OF RADIOTHERAPY AND NEURAMINIDASE-TREATED TUMOR-CELLS ON 3-METHYLCHOLANTHRENE-INDUCED FIBROSARCOMA. JOURNAL OF SURGICAL ONCOLOGY, 9(6), 527–540.
- FAILING OR THROMBOSED BRESCIA-CIMINO ARTERIOVENOUS DIALYSIS FISTULAS - ANGIOGRAPHIC EVALUATION AND PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY
  Hunter, D. W., So, S. K. S., CASTANEDAZUNIGA, W. R., Coleman, C. E., Sutherland, D. E. R., & Amplatz, K. (1983). FAILING OR THROMBOSED BRESCIA-CIMINO ARTERIOVENOUS DIALYSIS FISTULAS - ANGIOGRAPHIC EVALUATION AND PERCUTANEOUS TRANS-LUMINAL ANGIOPLASTY. RADIOLOGY, 149(1), 105–109.
- LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY IN RENAL-TRANSPLANT PATIENTS - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY
  Sutherland, D. E. R., FRYD, D. S., So, S. K. S., Bentley, F. R., Ascher, N. L., SIMMONS, R. L., & Najarian, J. S. (1984). LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY IN RENAL-TRANSPLANT PATIENTS - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY. TRANSPLANTATION, 38(6), 619–624.
- HICKMAN CATHETER FOR PEDIATRIC HEMODIALYSIS - A 3-YEAR EXPERIENCE
  So, S. K. S., Mahan, J. D., Mauer, S. M., Sutherland, D. E. R., & Nevins, T. E. (1984). HICKMAN CATHETER FOR PEDIATRIC HEMODIALYSIS - A 3-YEAR EXPERIENCE. TRANSACTIONS AMERICAN SOCIETY FOR ARTIFICIAL INTERNAL ORGANS, 30, 619–623.
- BILE ASCITES DURING INFANCY - DIAGNOSIS USING DISOFENIN TC 99M SEQUENTIAL SCINTIPHOTOGRAPHY
  So, S. K. S., Lindahl, J. A., Sharp, H. L., Cook, A. M., & Leonard, A. S. (1983). BILE ASCITES DURING INFANCY - DIAGNOSIS USING DISOFENIN TC 99M SEQUENTIAL SCINTIPHOTOGRAPHY. PEDIATRICS, 71(3), 402–405.
- HBV markers in Chinese in Hong Kong.
  Lam, K. C., Yuen, P., COLBOURNE, M. J., Chang, J., & So, S. (1980). HBV markers in Chinese in Hong Kong. Annals of the Academy of Medicine, Singapore, 9(2), 149–151.
- THE USE OF NON-HEART-BEATING CADAVER DONORS IN EXPERIMENTAL LIVER-TRANSPLANTATION
  Tojimbara, T., Kennedy, R. G., BURNS, W., Hayashi, M., Krams, S., Martinez, O., … Esquivel, C. O. (1995). THE USE OF NON-HEART-BEATING CADAVER DONORS IN EXPERIMENTAL LIVER-TRANSPLANTATION. TRANSPLANTATION, 60(10), 1179–1180.
- FULMINANT HEPATIC-FAILURE FOLLOWING VARICELLA-ZOSTER INFECTION IN A CHILD - A CASE-REPORT OF SUCCESSFUL TREATMENT WITH LIVER-TRANSPLANTATION AND PERIOPERATIVE ACYCLOVIR
  Tojimbara, T., So, S. K., Cox, K. L., Berquist, W. E., Egawa, H., GARCIAKENNEDY, R., & Esquivel, C. O. (1995). FULMINANT HEPATIC-FAILURE FOLLOWING VARICELLA-ZOSTER INFECTION IN A CHILD - A CASE-REPORT OF SUCCESSFUL TREATMENT WITH LIVER-TRANSPLANTATION AND PERIOPERATIVE ACYCLOVIR. TRANSPLANTATION, 60(9), 1052–1053.
- FK506 CONVERSION THERAPY IN PEDIATRIC LIVER-TRANSPLANTATION
  Egawa, H., Esquivel, C. O., So, S. K., Cox, K., Concepcion, W., & Lawrence, L. (1994). FK506 CONVERSION THERAPY IN PEDIATRIC LIVER-TRANSPLANTATION. TRANSPLANTATION, 57(8), 1169–73.
- AN INCREASED INCIDENCE OF EPSTEIN-BARR-VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG-CHILDREN ON FK506 AFTER LIVER-TRANSPLANTATION
  Cox, K. L., LAWRENCEMIYASAKI, L. S., GARCIAKENNEDY, R., Lennette, E. T., Martinez, O. M., Krams, S. M., … Esquivel, C. O. (1995). AN INCREASED INCIDENCE OF EPSTEIN-BARR-VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDER IN YOUNG-CHILDREN ON FK506 AFTER LIVER-TRANSPLANTATION. TRANSPLANTATION, 59(4), 524–529.
- DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (CICAM-1) AND VASCULAR CELL-ADHESION MOLECULE-1 (CVCAM-1) DURING LIVER ALLOGRAFT-REJECTION
  Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., & Martinez, O. M. (1995). DIFFERENTIAL PATTERNS OF CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 (CICAM-1) AND VASCULAR CELL-ADHESION MOLECULE-1 (CVCAM-1) DURING LIVER ALLOGRAFT-REJECTION. TRANSPLANTATION, 59(4), 584–589.
- DISTINCT PATTERNS OF TH2 CYTOKINE PRODUCTION DURING IMMUNE ACTIVATION IN PEDIATRIC LIVER ALLOGRAFT RECIPIENTS
  Lang, T., Krams, S. M., Villanueva, J. C., Cox, K., So, S., Esquivel, C., & Martinez, O. M. (1995). DISTINCT PATTERNS OF TH2 CYTOKINE PRODUCTION DURING IMMUNE ACTIVATION IN PEDIATRIC LIVER ALLOGRAFT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1146–1147.
- CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND VASCULAR CELL-ADHESION MOLECULE-1 IN PEDIATRIC LIVER RECIPIENTS
  Lang, T., Krams, S. M., Villanueva, J. C., So, S. K., Berquist, W. E., Cox, K. L., … Martinez, O. M. (1995). CIRCULATING INTERCELLULAR-ADHESION MOLECULE-1 AND VASCULAR CELL-ADHESION MOLECULE-1 IN PEDIATRIC LIVER RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1148–1149.
- MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS
  Martinez, O. M., Villanueva, J. C., LAWRENCEMIYASAKI, L., QUINN, M. B., Gish, R., Cox, K., … Krams, S. M. (1995). MOLECULAR MARKERS OF EPSTEIN-BARR-VIRUS INFECTION IN THE CIRCULATION OF TRANSPLANT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 27(1), 1211–1212.
- LONG-TERM NONRESPONSIVENESS TO A LIVER ALLOGRAFT MAY BE CYTOKINE-MEDIATED
  Egawa, H., Martinez, O. M., QUINN, M. B., Villanueva, J. C., So, S., Esquivel, C. O., & Krams, S. M. (1995). LONG-TERM NONRESPONSIVENESS TO A LIVER ALLOGRAFT MAY BE CYTOKINE-MEDIATED. TRANSPLANTATION PROCEEDINGS, 27(1), 241–242.
- ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA
  Egawa, H., Berquist, W., So, S. K., Cox, K., Menegaux, F., & Esquivel, C. O. (1995). ISOLATED ALKALINE PHOSPHATEMIA FOLLOWING PEDIATRIC LIVER-TRANSPLANTATION IN THE FK506 ERA. TRANSPLANTATION, 59(5), 791–793.
- FK-506 RESCUE THERAPY FOR HEPATIC ALLOGRAFT-REJECTION - EXPERIENCE WITH AN AGGRESSIVE APPROACH
  Woodle, E. S., Perdrizet, G. A., So, S. K. S., White, H. M., & Marsh, J. W. (1995). FK-506 RESCUE THERAPY FOR HEPATIC ALLOGRAFT-REJECTION - EXPERIENCE WITH AN AGGRESSIVE APPROACH. CLINICAL TRANSPLANTATION, 9(1), 45–52.
- Liver transplantation at California Pacific Medical Center, San Francisco, California.
  Esquivel, C. O., Martinez, O., Krams, S., Lim, J., So, S. K., Concepcion, W., … Keeffe, E. B. (1994). Liver transplantation at California Pacific Medical Center, San Francisco, California. Clinical Transplants, 163–71.
- A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION
  Cacciarelli, T. V., So, S. K. S., Lim, J., Concepcion, W., Cox, K., & Esquivel, C. O. (1995). A REASSESSMENT OF ABO INCOMPATIBILITY IN PEDIATRIC LIVER-TRANSPLANTATION. TRANSPLANTATION, 60(7), 757–60.
- RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION
  Woodle, E. S., So, S., Jendrisak, M. D., Perdrizet, G. A., White, H. M., & Marsh, J. W. (1993). RECURRENT REJECTION FOLLOWING FK-506 RESCUE THERAPY FOR ACUTE HEPATIC ALLOGRAFT-REJECTION. TRANSPLANTATION PROCEEDINGS, 25(2), 1988–1989.
- FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY
  Woodle, E. S., Perdrizet, G. A., So, S., Jendrisak, M. D., White, H. M., & Marsh, J. W. (1993). FK-506 RESCUE THERAPY - EARLY CONVERSION IMPROVES EFFICACY. TRANSPLANTATION PROCEEDINGS, 25(2), 1990–1991.
- FK-506 RESCUE THERAPY - THE RAPIDITY OF REJECTION REVERSAL IS RELATED TO THE SUBSEQUENT DEVELOPMENT OF CMV DISEASE
  Woodle, E. S., Perdrizet, G. A., So, S., Jendrisak, M. D., White, H. M., & Marsh, J. W. (1993). FK-506 RESCUE THERAPY - THE RAPIDITY OF REJECTION REVERSAL IS RELATED TO THE SUBSEQUENT DEVELOPMENT OF CMV DISEASE. TRANSPLANTATION PROCEEDINGS, 25(2), 1992–1993.
- EFFECTS OF PENTOXIFYLLINE PRETREATMENT ON KUPFFER CELLS IN RAT-LIVER TRANSPLANTATION
  Kozaki, K., Egawa, H., Bermudez, L., Keefe, E. B., So, S. K., & Esquivel, C. O. (1995). EFFECTS OF PENTOXIFYLLINE PRETREATMENT ON KUPFFER CELLS IN RAT-LIVER TRANSPLANTATION. HEPATOLOGY, 21(4), 1079–1082.
- LIVER-TRANSPLANTATION IN A CHILD WITH SICKLE-CELL-ANEMIA
  Lang, T., Berquist, W. E., So, S. K., Cox, K. L., RICH, E. J., Vichinsky, E., … Esquivel, C. O. (1995). LIVER-TRANSPLANTATION IN A CHILD WITH SICKLE-CELL-ANEMIA. TRANSPLANTATION, 59(10), 1490–1492.
- ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ANALYSIS OF THE IMMUNE RESPONSE
  Egawa, H., Martinez, O. M., QUINN, M. B., Villanueva, J. C., So, S., Esquivel, C. O., & Krams, S. M. (1995). ACUTE LIVER ALLOGRAFT-REJECTION IN THE RAT - AN ANALYSIS OF THE IMMUNE RESPONSE. TRANSPLANTATION, 59(1), 97–102.
- IMPACT OF REDUCED-SIZE LIVER-TRANSPLANTATION ON REJECTION AND LIVER ALLOGRAFT OUTCOME IN THE PEDIATRIC POPULATION
  Cacciarelli, T. V., So, S. K. S., Egawa, H., Cox, K., & Esquivel, C. O. (1995). IMPACT OF REDUCED-SIZE LIVER-TRANSPLANTATION ON REJECTION AND LIVER ALLOGRAFT OUTCOME IN THE PEDIATRIC POPULATION. TRANSPLANTATION PROCEEDINGS, 27(1), 1239–1240.
- CHARACTERIZATION OF CYTOKINE EXPRESSION IN AN ANIMAL-MODEL OF ACUTE LIVER ALLOGRAFT-REJECTION
  Egawa, H., Martinez, O. M., QUINN, M. B., So, S., Esquivel, C. O., & Krams, S. M. (1995). CHARACTERIZATION OF CYTOKINE EXPRESSION IN AN ANIMAL-MODEL OF ACUTE LIVER ALLOGRAFT-REJECTION. TRANSPLANTATION PROCEEDINGS, 27(1), 505–506.
- EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION
  Wong, L., Concepcion, W., So, S. K., Egawa, H., Menegaux, F., & Esquivel, C. O. (1994). EX-VIVO TECHNIQUE FOR RIGHT LOBECTOMY IN PEDIATRIC HEPATIC TRANSPLANTATION. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 179(5), 601–603.
- RESPIRATORY-DISTRESS FROM BENIGN LIVER-TUMORS - A REPORT OF 2 UNUSUAL CASES TREATED WITH HEPATIC TRANSPLANTATION
  Egawa, H., Berquist, W., GARCIAKENNEDY, R., Cox, K. L., Concepcion, W., So, S. K., & Esquivel, C. O. (1994). RESPIRATORY-DISTRESS FROM BENIGN LIVER-TUMORS - A REPORT OF 2 UNUSUAL CASES TREATED WITH HEPATIC TRANSPLANTATION. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 19(1), 114–117.
- NEUROLOGICAL COMPLICATIONS OF LIVER-TRANSPLANTATION IN ADULT VERSUS PEDIATRIC-PATIENTS
  Menegaux, F., Keeffe, E. B., Andrews, B. T., Egawa, H., Monge, H., Concepcion, W., … Esquivel, C. O. (1994). NEUROLOGICAL COMPLICATIONS OF LIVER-TRANSPLANTATION IN ADULT VERSUS PEDIATRIC-PATIENTS. TRANSPLANTATION, 58(4), 447–450.
- INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY-TRANSPLANTATION
  Hanto, D. W., Jendrisak, M. D., So, S. K. S., McCullough, C. S., Rush, T. M., MICHALSKI, S. M., … Mohanakumar, T. (1994). INDUCTION IMMUNOSUPPRESSION WITH ANTILYMPHOCYTE GLOBULIN OR OKT3 IN CADAVER KIDNEY-TRANSPLANTATION. TRANSPLANTATION, 57(3), 377–384.
- AGGRESSIVE EARLY CYCLOSPORINE THERAPY IS DESIRABLE IN PEDIATRIC RENAL TRANSPLANTATION
  ALUZRI, A., Conley, S. B., Orlandi, P., So, S., & Salvatierra, O. (1994). AGGRESSIVE EARLY CYCLOSPORINE THERAPY IS DESIRABLE IN PEDIATRIC RENAL TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 26(1), 88–90.
- PREVENTION OF REJECTION AND GRAFT LOSS WITH AN AGGRESSIVE QUADRUPLE IMMUNOSUPPRESSIVE THERAPY REGIMEN IN CHILDREN AND ADOLESCENTS
  Conley, S. B., ALUZRI, A., So, S., & Salvatierra, O. (1994). PREVENTION OF REJECTION AND GRAFT LOSS WITH AN AGGRESSIVE QUADRUPLE IMMUNOSUPPRESSIVE THERAPY REGIMEN IN CHILDREN AND ADOLESCENTS. TRANSPLANTATION, 57(4), 540–544.
- PENTOXIFYLLINE INHIBITS PRODUCTION OF SUPEROXIDE ANION AND TUMOR-NECROSIS-FACTOR BY KUPFFER CELLS IN RAT-LIVER PRESERVATION
  Kozaki, K., Egawa, H., BERMUDES, L., Feduska, N. J., So, S., & Esquivel, C. O. (1993). PENTOXIFYLLINE INHIBITS PRODUCTION OF SUPEROXIDE ANION AND TUMOR-NECROSIS-FACTOR BY KUPFFER CELLS IN RAT-LIVER PRESERVATION. TRANSPLANTATION PROCEEDINGS, 25(6), 3025–3026.
- COMPARATIVE EFFECTS OF BLOOD, COLLOID, AND RINGERS LACTATE TERMINAL ALLOGRAFT RINSE ON THE RESULTS OF ORTHOTOPIC LIVER-TRANSPLANTATION
  Menegaux, F., Egawa, H., Keeffe, E. B., So, S. K., Concepcion, W., Collins, G. M., & Esquivel, C. O. (1993). COMPARATIVE EFFECTS OF BLOOD, COLLOID, AND RINGERS LACTATE TERMINAL ALLOGRAFT RINSE ON THE RESULTS OF ORTHOTOPIC LIVER-TRANSPLANTATION. TRANSPLANTATION PROCEEDINGS, 25(6), 3196–3198.
- CYTOMEGALOVIRUS PROPHYLAXIS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
  So, S., Mayo, C., McCullough, C., Jendrisak, M., Woodle, S., Marsh, W., & Bailey, T. (1993). CYTOMEGALOVIRUS PROPHYLAXIS IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS. TRANSPLANTATION PROCEEDINGS, 25(1), 1414–1415.
- SUCCESSFUL RETRANSPLANTATION AFTER A 48-HOUR ANHEPATIC STATE
  So, S. K. S., BARTEAU, J. A., Perdrizet, G. A., & Marsh, J. W. (1993). SUCCESSFUL RETRANSPLANTATION AFTER A 48-HOUR ANHEPATIC STATE. TRANSPLANTATION PROCEEDINGS, 25(2), 1962–1963.
- INTRAHEPATIC PORTOSYSTEMIC VASCULAR STENTS - A BRIDGE TO HEPATIC TRANSPLANTATION
  Woodle, E. S., Darcy, M., White, H. M., Perdrizet, G. A., Vesely, T. M., Picus, D., … Marsh, J. W. (1993). INTRAHEPATIC PORTOSYSTEMIC VASCULAR STENTS - A BRIDGE TO HEPATIC TRANSPLANTATION. SURGERY, 113(3), 344–351.
- Expression of cytokines and immune mediators during chronic liver allograft rejection
  Hayashi, M., Martinez, O. M., GARCIAKENNEDY, R., So, S., Esquivel, C. O., & Krams, S. M. (1995). Expression of cytokines and immune mediators during chronic liver allograft rejection. TRANSPLANTATION, 60(12), 1533–1538.
- Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients
  Esquivel, C. O., So, S. K., McDiarmid, S. V., Andrews, W. S., & Colombani, P. M. (1996). Suggested guidelines for the use of tacrolimus in pediatric liver transplant patients. TRANSPLANTATION, 61(5), 847–848.
- Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation
  Cacciarelli, T. V., Esquivel, C. O., Cox, K. L., Hayashi, M., Berquist, W. E., Concepcion, W., & So, S. K. S. (1996). Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation. TRANSPLANTATION, 61(8), 1188–92.
- Cyclosporine and tacrolimus both suppress activation of kupffer cells in vitro
  Tojimbara, T., Bermudez, L. E., Egawa, H., Hayashi, M., So, S. K., & Esquivel, C. O. (1996). Cyclosporine and tacrolimus both suppress activation of kupffer cells in vitro. TRANSPLANTATION PROCEEDINGS, 28(3), 1381–82.
- Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting - Bridge to liver transplantation
  Hammer, G. B., So, S. K. S., ALUZRI, A., Conley, S. B., Concepcion, W., Cox, K. L., … Esquivel, C. O. (1996). Continuous venovenous hemofiltration with dialysis in combination with total hepatectomy and portocaval shunting - Bridge to liver transplantation. TRANSPLANTATION, 62(1), 130–32.
- Orthotopic liver transplantation for hepatocellular carcinoma - Factors affecting long-term patient survival
  Ojogho, O. N., So, S. K. S., Keeffe, E. B., Berquist, W., Concepcion, W., GARCIAKENNEDY, R., … Esquivel, C. O. (1996). Orthotopic liver transplantation for hepatocellular carcinoma - Factors affecting long-term patient survival. ARCHIVES OF SURGERY, 131(9), 935–39.
- Primary liver transplantation without transfusion of red blood cells
  Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Chuljian, P., Busque, S., … Esquivel, C. O. (1996). Primary liver transplantation without transfusion of red blood cells. SURGERY, 120(4), 698–704.
- Liver transplantation in Asian patients with chronic hepatitis B
  HO, B. M., So, S. K., Esquivel, C. O., & Keeffe, E. B. (1997). Liver transplantation in Asian patients with chronic hepatitis B. HEPATOLOGY, 25(1), 223–25.
- Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report
  Cao, S., Monge, H., Semba, C., Cox, K. L., Berquist, W., Concepcion, W., … Esquivel, C. O. (1997). Emergency transjugular intrahepatic portosystemic shunt (TIPS) in an infant: A case report. JOURNAL OF PEDIATRIC SURGERY, 32(1), 125–27.
- Orthotopic liver transplantation from non-heart-beating donor rats: Effect of flushing with cold/warm UW/SLS preservation solutions
  Tojimbara, T., Winston, W. N., So, S. K., & Esquivel, C. O. (1997). Orthotopic liver transplantation from non-heart-beating donor rats: Effect of flushing with cold/warm UW/SLS preservation solutions. TRANSPLANTATION PROCEEDINGS, 29(1-2), 1371–1373.
- Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients
  Cao, S., Cox, K., So, S. S. K., Berquist, W., Lee, S. P., Haigh, W. G., … Esquivel, C. O. (1997). Potential effect of cyclosporin A in formation of cholesterol gallstones in pediatric liver transplant recipients. DIGESTIVE DISEASES AND SCIENCES, 42(7), 1409–15.
- Factors affecting survival after orthotopic liver transplantation in infants
  Cacciarelli, T. V., Esquivel, C. O., Moore, D. H., Cox, K. L., Berquist, W. E., Concepcion, W., … So, S. K. S. (1997). Factors affecting survival after orthotopic liver transplantation in infants. TRANSPLANTATION, 64(2), 242–48.
- Superior outcomes in pediatric renal transplantation
  Salvatierra, O., Alfrey, E., Tanney, D. C., Mak, R., Hammer, G. B., Krane, E. J., … Conley, S. B. (1997). Superior outcomes in pediatric renal transplantation. ARCHIVES OF SURGERY, 132(8), 842–47.
- Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy
  Wang, J., Cox, K. L., Dake, M., Esquivel, C. O., & So, S. K. S. (1997). Transjugular intrahepatic portosystemic shunt placement in a child complicated by perforated Roux-en-Y portoenterostomy. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 25(4), 421–25.
- Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
  Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., Keeffe, E. B., … Wiesner, R. H. (1997). Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transplantation and Surgery , 3(6), 628–637.
- Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation
  Busque, S., Esquivel, C. O., Concepcion, W., & So, S. K. S. (1998). Experience with the piggyback technique without caval occlusion in adult orthotopic liver transplantation. TRANSPLANTATION, 65(1), 77–82.
- Allograft rejection after liver transplantation for autoimmune liver diseases
  Hayashi, M., Keeffe, E. B., Krams, S. M., Martinez, O. M., Ojogho, O. N., So, S. K. S., … Esquivel, C. O. (1998). Allograft rejection after liver transplantation for autoimmune liver diseases. LIVER TRANSPLANTATION AND SURGERY, 4(3), 208–14.
- Liver transplantation in the first three months of life
  Woodle, E. S., Millis, J. M., So, S. K. S., McDiarmid, S. V., Busuttil, R. W., Esquivel, C. O., … Thistlethwaite, J. R. (1998). Liver transplantation in the first three months of life. TRANSPLANTATION, 66(5), 606–609.
- Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation
  Cao, S., Cox, K., Esquivel, C. O., Berquist, W., Concepcion, W., Ojogho, O., … So, S. (1998). Posttransplant lymphoproliferative disorders and gastrointestinal manifestations of Epstein-Barr virus infection in children following liver transplantation. TRANSPLANTATION, 66(7), 851–56.
- Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases.
  Lucey, M. R., Brown, K. A., Everson, G. T., Fung, J. J., Gish, R., Keefe, E. B., … Wiesner, R. H. (1998). Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation, 66(7), 956–962.
- Increased dosage requirement and rejection after neoral conversion in pediatric liver transplant patients
  Cao, S., Cox, K. L., Berquist, W., So, S., Concepcion, W., Monge, H., & Esquivel, C. O. (1998). Increased dosage requirement and rejection after neoral conversion in pediatric liver transplant patients. TRANSPLANTATION PROCEEDINGS, 30(8), 4322–24.
- Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation
  Cacciarelli, T. V., Keeffe, E. B., Moore, D. H., BURNS, W., Busque, S., Concepcion, W., … Esquivel, C. O. (1999). Effect of intraoperative blood transfusion on patient outcome in hepatic transplantation. ARCHIVES OF SURGERY, 134(1), 25–29.
- Liver transplantation for hepatocellular carcinoma and the role of preoperative chemoembolization.
  Millan, M. T., Lai, K. M., Keeffe, E. B., Fisher, G. A., Razavi, M. K., Prapong, W., … So, S. K. S. (2000). Liver transplantation for hepatocellular carcinoma and the role of preoperative chemoembolization. TRANSPLANTATION, 69(8), S215–S215.
- Genome-wide study of human hepatocellular carcinoma with 23K cDNA microarray.
  Chen, X., Cheung, S., Barry, C., Fan, S., Lai, K. M., Ji, J. F., … So, S. (2000). Genome-wide study of human hepatocellular carcinoma with 23K cDNA microarray. HEPATOLOGY, 32(4), 324A–324A.
- Genomic analysis of human hepatocellular carcinoma gene expression using cDNA microarrays.
  Barry, C. T., MILLAN, M., Monge, H., Esquivel, C., BROWN, P., & So, S. (1999). Genomic analysis of human hepatocellular carcinoma gene expression using cDNA microarrays. TRANSPLANTATION, 67(7), S142–S142.
- CD81 gene expression is lost in hepatocellular carcinoma.
  Drazan, K. E., Higgins, J., Fisher, G. A., Keefe, E., Barry, C. T., So, S. S., … Esquivel, C. O. (1999). CD81 gene expression is lost in hepatocellular carcinoma. HEPATOLOGY, 30(4), 248A–248A.
- High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California.
  Chao, S., Le, P. V., Prapong, W., Su, J., & So, S. (2004). High prevalence of chronic hepatitis B (HBV) infection in adult Chinese Americans living in California. HEPATOLOGY, 40(4), 717A–717A.
- PRELIMINARY-RESULTS OF RENAL-TRANSPLANTATION IN CHILDREN UNDER 1 YEAR OF AGE
  So, S. K. S., Nevins, T. E., Chang, P. N., Mauer, S. M., Ascher, N. L., FRYD, D. S., … Najarian, J. S. (1985). PRELIMINARY-RESULTS OF RENAL-TRANSPLANTATION IN CHILDREN UNDER 1 YEAR OF AGE. TRANSPLANTATION PROCEEDINGS, 17(1), 182–183.
- THE LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY ON RENAL-ALLOGRAFT SURVIVAL - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY
  Sutherland, D. E. R., FRYD, D. S., So, S. K. S., Strand, M., Ascher, N. L., SIMMONS, R. L., & Najarian, J. S. (1985). THE LONG-TERM EFFECT OF SPLENECTOMY VERSUS NO SPLENECTOMY ON RENAL-ALLOGRAFT SURVIVAL - REANALYSIS OF A RANDOMIZED PROSPECTIVE-STUDY. TRANSPLANTATION PROCEEDINGS, 17(1), 136–137.
- A phase II study of imatinib mesylate (IM) in patients (pts) with unresectable hepatocellular carcinoma (HCC).
  LIN, A. Y., Fisher, G., So, S., Tang, C., & Levitt, L. (2005). A phase II study of imatinib mesylate (IM) in patients (pts) with unresectable hepatocellular carcinoma (HCC). JOURNAL OF CLINICAL ONCOLOGY, 23(16), 363S–363S.
- Identification of a 14-gene signature that predicts survival in colorectal cancer with liver metastasis
  Chung, J. L., Pollack, J., Chua, M.-S., So, S., Lin, C.-D., & Lin, A. Y. (2012). Identification of a 14-gene signature that predicts survival in colorectal cancer with liver metastasis. JOURNAL OF CLINICAL ONCOLOGY. CHICAGO,IL,IL,IL,IL,IL: AMER SOC CLINICAL ONCOLOGY.
- OPTICAL IMAGING OF LIVER CARCINOMA XENOGRAFTS USING EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED FLUORESCENTLY LABELED AFFIBODY
  Zhao, P., Yang, X., Qi, S., Cao, Q., Chua, M.-S., Wang, J., … Cheng, Z. (2011). OPTICAL IMAGING OF LIVER CARCINOMA XENOGRAFTS USING EPIDERMAL GROWTH FACTOR RECEPTOR TARGETED FLUORESCENTLY LABELED AFFIBODY. Presented at the 62nd Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases (AASLD), SAN FRANCISCO,CA,CA,CA,CA: WILEY-BLACKWELL.
- Prevalence of HBV and risk of HBV acquisition in hepatitis B screening programs in large metropolitan cities in the United States.
  Guane, R., Siu, P., Lam, K., Kim, K. E., Warren, V., Liu, H., … Brosgrat, C. L. (2004). Prevalence of HBV and risk of HBV acquisition in hepatitis B screening programs in large metropolitan cities in the United States. HEPATOLOGY, 40(4), 716A–716A.
- Combined viral prophylactic and immunosuppressive strategy in liver transplantation (OLT) for HBV cirrhosis
  So, S. K. S., Esquivel, C. O., Imperial, J. C., Garcia, G., & Keeffe, E. B. (1998). Combined viral prophylactic and immunosuppressive strategy in liver transplantation (OLT) for HBV cirrhosis. HEPATOLOGY, 28(4), 346A–346A.
- MOLECULAR EFFECTS OF SUPPRESSING THE CDC37 COCHAPERONE IN HEPATOCELLULAR CARCINOMA INHIBITS CELL CYCLE PROGRESSION AND CELL GROWTH
  Wang, Z., Wei, W., Sun, K.-W., Chua, M.-S., & So, S. (2012). MOLECULAR EFFECTS OF SUPPRESSING THE CDC37 COCHAPERONE IN HEPATOCELLULAR CARCINOMA INHIBITS CELL CYCLE PROGRESSION AND CELL GROWTH. Presented at the 47th Annual Meeting of the European-Association-for-the-Study-of-the-Liver (EASL), BARCELONA,SPAIN,SPAIN: ELSEVIER SCIENCE BV.
- Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes
  Kane, R., Solomon, H., Friedman, B., Heffron, T., DePaolo, J., Sokol, R. J., … Spaith, E. (2001). Studies of Pediatric Liver Transplantation (SPLIT): Year 2000 outcomes. TRANSPLANTATION, 72(3), 463–476.
- FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL
  McDiarmid, S. V., Busuttil, R. W., Ascher, N. L., Burdick, J., DALESSANDRO, A. M., Esquivel, C., … So, S. K. (1995). FK506 (TACROLIMUS) COMPARED WITH CYCLOSPORINE FOR PRIMARY IMMUNOSUPPRESSION AFTER PEDIATRIC LIVER-TRANSPLANTATION - RESULTS FROM THE US MULTICENTER TRIAL. TRANSPLANTATION, 59(4), 530–536.
- IMMUNOSPECIFIC LYMPHOCYTE-MEDIATED INJURY OF ISOLATED HEPATOCYTES
  Harty, J. T., So, S. K. S., Keller, G. A., Hoffman, R., Ascher, N. L., & SIMMONS, R. L. (1985). IMMUNOSPECIFIC LYMPHOCYTE-MEDIATED INJURY OF ISOLATED HEPATOCYTES. TRANSPLANTATION PROCEEDINGS, 17(1), 606–607.
- HEPATOCYTES ARE ALLOSPECIFIC TARGETS FOR CYTOLYTIC LYMPHOCYTE CLONES
  So, S. K. S., Harty, J. T., Hoffman, R. A., Platt, J. L., BIEL, L. W., & SIMMONS, R. L. (1985). HEPATOCYTES ARE ALLOSPECIFIC TARGETS FOR CYTOLYTIC LYMPHOCYTE CLONES. SURGICAL FORUM, 36, 331–333.
- OKT3 REVERSAL OF BIOPSY-PROVEN ALLOGRAFT-REJECTION OCCURRING DURING MINNESOTA ANTILYMPHOBLAST GLOBULIN INDUCTION IN THE PEDIATRIC RENAL RECIPIENT
  Bunchman, T. E., Kershaw, D. B., Merion, R. M., Ham, J. M., Sedman, A. B., KELSCH, R. C., … So, S. K. S. (1993). OKT3 REVERSAL OF BIOPSY-PROVEN ALLOGRAFT-REJECTION OCCURRING DURING MINNESOTA ANTILYMPHOBLAST GLOBULIN INDUCTION IN THE PEDIATRIC RENAL RECIPIENT. CLINICAL TRANSPLANTATION, 7(3), 219–222.
- Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives
  Ma, L., Chua, M.-S., Andrisani, O., & So, S. (2014). Epigenetics in hepatocellular carcinoma: An update and future therapy perspectives. WORLD JOURNAL OF GASTROENTEROLOGY, 20(2), 333–45.
- Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma.
  Lu, W.-J., Chua, M.-S., & So, S. K. (2014). Suppressing N-Myc downstream regulated gene 1 reactivates senescence signaling and inhibits tumor growth in hepatocellular carcinoma. Carcinogenesis, 35(4), 915–22.
- Imaging of hepatocellular carcinoma patient-derived xenografts using Zr-89-labeled anti-glypican-3 monoclonal antibody
  Yang, X., Liu, H., Sun, C. K., Natarajan, A., Hu, X., Wang, X., … So, S. K. (2014). Imaging of hepatocellular carcinoma patient-derived xenografts using Zr-89-labeled anti-glypican-3 monoclonal antibody. BIOMATERIALS, 35(25), 6964–71.
- Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts.
  Wei, W., Wu, S., Wang, X., Sun, C. K. W., Yang, X., Yan, X., … So, S. (2014). Novel celastrol derivatives inhibit the growth of hepatocellular carcinoma patient-derived xenografts. Oncotarget, 5(14), 5819–31.
- Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
  Wang, Z., Wei, W., Sun, C. K., Chua, M.-S., & So, S. (2015). Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth. Liver International , 35(4), 1403–15.
- Wnt pathway activation in hepatocellular carcinoma: A clinical perspective.
  Ma, L., Wei, W., Chua, M.-S., & So, S. (2014). Wnt pathway activation in hepatocellular carcinoma: A clinical perspective. . Gastrointestinal Cancer: Targets and Therapy, 4.
- Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment
  Toy, M., Demirci, U., & So, S. (2014). Preventing hepatocellular carcinoma: the crucial role of chronic hepatitis B monitoring and antiviral treatment. Hepatic Oncology, 1(3).
- Glypican-3-Mediates Autophagy and Promotes Self-Renewal and Tumor Initiation of Hepatocellular Carcinoma Cells
  SUN, C. H. R. I. S., CHUA, M. E. I.-S. Z. E., WEI, W. E. I., & SO, S. A. M. U. E. L. (2014). Glypican-3-Mediates Autophagy and Promotes Self-Renewal and Tumor Initiation of Hepatocellular Carcinoma Cells. Journal of Stem Cell Research & Therapy, 4(9).
- Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013
  Naghavi, M., Wang, H., Lozano, R., Davis, A., Liang, X., Zhou, M., … Murray, C. J. L. (2015). Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. LANCET, 385(9963), 117–71.
- Medical training fails to prepare providers to care for patients with chronic hepatitis B infection.
  Chao, S. D., Wang, B.-mei, Chang, E. T., Ma, L., & So, S. K. (2015). Medical training fails to prepare providers to care for patients with chronic hepatitis B infection. World Journal of Gastroenterology , 21(22), 6914–23.
- Tankyrase inhibitors attenuate WNT/ß-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
  Ma, L., Wang, X., Jia, T., Wei, W., Chua, M.-S., & So, S. (2015). Tankyrase inhibitors attenuate WNT/ß-catenin signaling and inhibit growth of hepatocellular carcinoma cells. Oncotarget, 6(28), 25390–401.
- NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3 beta and Nur77 to prevent beta-catenin degradation
  Lu, W.-J., Chua, M.-S., Wei, W., & So, S. K. (2015). NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3 beta and Nur77 to prevent beta-catenin degradation. ONCOTARGET, 6(30), 29847–59.
- Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer
  Yung, M. K., Lo, K. W., Yip, C. W., Chung, G. T. Y., Tong, C. Y. K., Cheung, P. F. Y., … Cheung, S. T. (2015). Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer. BMC CANCER, 15.
- Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China.
  Toy, M., Hutton, D. W., & So, S. K. (2015). Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in China. PloS One, 10(11).
- Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53-and p38-mediated apoptotic signaling
  Lu, W.-J., Chua, M.-S., & So, S. K. (2015). Suppression of ATAD2 inhibits hepatocellular carcinoma progression through activation of p53-and p38-mediated apoptotic signaling. ONCOTARGET, 6(39), 41722–35.
- Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China.
  Wang, J., Feng, Q., Tam, A., Sun, T., Zhou, P., & So, S. (2016). Evaluation of the first open-access hepatitis B and safe injection online training course for health professionals in China. BMC Medical Education, 16(1), 81-?
- The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013.
  Stanaway, J. D., Flaxman, A. D., Naghavi, M., Fitzmaurice, C., Vos, T., Abubakar, I., … Cooke, G. S. (2016). The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013. Lancet , 388(10049), 1081–88.
- Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C
  Colvin, H. M., Mitchell, A. E., Beaseley, R. P., Alter, H. J., Brandeau, M. L., Church, D. R., … Wright, L. N. (2010). Hepatitis and Liver Cancer: A National Strategy for Prevention and Control of Hepatitis B and C (p. 176). Washington, D.C.: Institute of Medicine. Retrieved from https://www.nap.edu/read/12793/chapter/1
- A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report
  Buckley, G. J., Strom, B. L., Andrus, J. K., Aronsohn, A., Church, D., Cohen, S., … Wilson, L. (2017). A National Strategy for the Elimination of Hepatitis B and C: Phase Two Report (p. 290). Washington, DC: National Academies of Sciences, Engineering and Medicine. Retrieved from http://www.nap.edu/24731
- Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report
  Buckley, G. J., Strom, B. L., Andrus, J. K., Aronsohn, A., Church, D., Cohen, S., … Wilson, L. (2016). Eliminating the Public Health Problem of Hepatitis B and C in the United States: Phase One Report (p. 180). Washington, DC: National Academies of Sciences, Engineering, and Medicine. Retrieved from http://www.nap.edu/23407
- The Jade Ribbon Campaign: a systematic, evidence-based public awareness campaign to improve Asian and Pacific Islander health
  Chao, S., & So, S. (2011). The Jade Ribbon Campaign: a systematic, evidence-based public awareness campaign to improve Asian and Pacific Islander health. Journal of Communication in Healthcare, 4(1).
- Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection
  Perumpail, R. B., Ahmed, A., Higgins, J. P., So, S. K., Cochran, J. L., Drobeniuc, J., … Teo, C.-G. (2015). Fatal Accelerated Cirrhosis after Imported HEV Genotype 4 Infection. EMERGING INFECTIOUS DISEASES, 21(9), 1679–81.
- Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study
  Fitzmaurice, C., Collaboration, G. B. D. C., Allen, C., Barber, R. M., Barregard, L., Bhutta, Z. A., … Naghavi, M. (2017). Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015 A Systematic Analysis for the Global Burden of Disease Study. JAMA ONCOLOGY, 3(4), 524–48.
- Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
  Chen, B., Wei, W., Ma, L., Yang, B., Gill, R. M., Chua, M.-S., … So, S. (2017). Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. Gastroenterology, 152(8), 2022–36.
- Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets.
  Chen, B., Ma, L., Paik, H., Sirota, M., Wei, W., Chua, M.-S. S., … Butte, A. J. (2017). Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nature Communications, 8, 16022.
- 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages.
  Song, C.-X. X., Yin, S., Ma, L., Wheeler, A., Chen, Y., Zhang, Y., … Quake, S. R. (2017). 5-Hydroxymethylcytosine signatures in cell-free DNA provide information about tumor types and stages. Cell Research.
- A transfer-RNA-derived small RNA regulates ribosome biogenesis.
  Kim, H. K., Fuchs, G., Wang, S., Wei, W., Zhang, Y., Park, H., … Kay, M. A. (2017). A transfer-RNA-derived small RNA regulates ribosome biogenesis. Nature, 552(7683), 57–62.
- Quantifiable real-time 3D ultrasound data acquisition and visualization
  Welch, J. N., Johnson, J., Badr, R., Bax, M., So, S., Krummel, T., & Shahidi, R. (2001). Quantifiable real-time 3D ultrasound data acquisition and visualization. CARS 2001: COMPUTER ASSISTED RADIOLOGY AND SURGERY, 1230, 1155–55.
- Differences in Hepatocellular Carcinoma Incidence and Survival Rates among Asian Mono-Ethnicities
  Cholankeril, G., Perumpail, R. B., Hu, M., Pham, E. A., Kumari, R., Gish, R., … Ahmed, A. (2016). Differences in Hepatocellular Carcinoma Incidence and Survival Rates among Asian Mono-Ethnicities. HEPATOLOGY. WILEY.
- Prevalence and predictors of hepatitis B immunization in adults without immunity for hepatitis B from 1999-2014: a population-based study of 27,713 adults in the US
  Le, M. H., Toy, M., Gane, E. J., So, S., & Nguyen, M. H. (2017). Prevalence and predictors of hepatitis B immunization in adults without immunity for hepatitis B from 1999-2014: a population-based study of 27,713 adults in the US. HEPATOLOGY, 66, 1004A.
- Suboptimal rates, trends and predictors of hepatitis B vaccination in a population-based sample of children and adolescents in the United States (US) between 1999 and 2014
  Le, M. H., Toy, M., Gane, E. J., So, S., & Nguyen, M. H. (2017). Suboptimal rates, trends and predictors of hepatitis B vaccination in a population-based sample of children and adolescents in the United States (US) between 1999 and 2014. HEPATOLOGY, 66, 1003A.
- Population Health And Economic Impacts Of Reaching Chronic Hepatitis B Diagnosis And Treatment Targets In The US.
  Toy, M., Hutton, D. W., & So, S. (2018). Population Health And Economic Impacts Of Reaching Chronic Hepatitis B Diagnosis And Treatment Targets In The US. Health Affairs (Project Hope), 37(7), 1033–40.
- A 3 ' tRNA Derived Small RNA (tsRNA) Affects Translation in Rapidly Dividing Cells and a Target for Hepatocellular Carcinoma
  Kim, H., Fuchs, G., Wang, S., Wei, W., Zhang, Y., Park, H., … Kay, M. A. (2017). A 3 ' tRNA Derived Small RNA (tsRNA) Affects Translation in Rapidly Dividing Cells and a Target for Hepatocellular Carcinoma. MOLECULAR THERAPY. CELL PRESS.
- Targeting activated Wnt/beta-catenin signaling by XAV939 and its derivative WXL-8 in hepatocellular carcinoma
  Ma, L., Wang, X., Wei, W., Chua, M.-S., & So, S. K. (2014). Targeting activated Wnt/beta-catenin signaling by XAV939 and its derivative WXL-8 in hepatocellular carcinoma. HEPATOLOGY. WILEY-BLACKWELL.
- Niclosamide ethanolamine inhibits growth of patient-derived hepatocellular carcinoma xenografts
  Chen, B., Wei, W., Chua, M.-S., Butte, A., & So, S. K. (2015). Niclosamide ethanolamine inhibits growth of patient-derived hepatocellular carcinoma xenografts. HEPATOLOGY. WILEY-BLACKWELL.
- Disparities in Hepatocellular Carcinoma Incidence by Race/Ethnicity and Geographic Area in California: Implications for Prevention.
  Yang, B., Liu, J. B., So, S. K., Han, S. S., Wang, S. S., Hertz, A., … Hsing, A. W. (2018). Disparities in Hepatocellular Carcinoma Incidence by Race/Ethnicity and Geographic Area in California: Implications for Prevention. Cancer.
- Perinatal transmission in infants of mothers with chronic hepatitis B in California
  Burgis, J. C., Kong, D., Salibay, C., Zipprich, J., Harriman, K., & So, S. (2017). Perinatal transmission in infants of mothers with chronic hepatitis B in California. WORLD JOURNAL OF GASTROENTEROLOGY, 23(27), 4942–49.
- Therapeutic targeting of glypican-3 using TGF-beta 2 as a novel treatment approach for HCC
  Sun, C. K., Chua, M.-sze, & So, S. (2012). Therapeutic targeting of glypican-3 using TGF-beta 2 as a novel treatment approach for HCC. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Identifying novel therapeutic targets in HCC through an integrated transcriptomics and pharmacogenomics approach
  Chen, B., Ma, L., Chua, M.-S., Butte, A., & So, S. K. (2015). Identifying novel therapeutic targets in HCC through an integrated transcriptomics and pharmacogenomics approach. HEPATOLOGY. WILEY-BLACKWELL.
- Viral Hepatitis Services
  Beasley, R. P., Alter, H. J., Brandeau, M. L., Church, D. R., Evans, A. A., Hagan, H., … Martinez, R. M. (2010). Viral Hepatitis Services. HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, 147–207.
- Immunization
  Beasley, R. P., Alter, H. J., Brandeau, M. L., Church, D. R., Evans, A. A., Hagan, H., … Martinez, R. M. (2010). Immunization. HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, 109–45.
- Knowledge and Awareness About Chronic Hepatitis B and Hepatitis C
  Beasley, R. P., Alter, H. J., Brandeau, M. L., Church, D. R., Evans, A. A., Hagan, H., … Martinez, R. M. (2010). Knowledge and Awareness About Chronic Hepatitis B and Hepatitis C. HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, 79–107.
- Surveillance
  Beasley, R. P., Alter, H. J., Brandeau, M. L., Church, D. R., Evans, A. A., Hagan, H., … Martinez, R. M. (2010). Surveillance. HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, 41–78.
- HEPATITIS AND LIVER CANCER A National Strategy for Prevention and Control of Hepatitis B and C Introduction
  Beasley, R. P., Alter, H. J., Brandeau, M. L., Church, D. R., Evans, A. A., Hagan, H., … Martinez, R. M. (2010). HEPATITIS AND LIVER CANCER A National Strategy for Prevention and Control of Hepatitis B and C Introduction. HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, 19–40.
- HEPATITIS AND LIVER CANCER A National Strategy for Prevention and Control of Hepatitis B and C Summary
  Beasley, R. P., Alter, H. J., Brandeau, M. L., Church, D. R., Evans, A. A., Hagan, H., … Martinez, R. M. (2010). HEPATITIS AND LIVER CANCER A National Strategy for Prevention and Control of Hepatitis B and C Summary. HEPATITIS AND LIVER CANCER: A NATIONAL STRATEGY FOR PREVENTION AND CONTROL OF HEPATITIS B AND C, 1–17.
- Prevalence of Hepatitis B Vaccination Coverage Versus Serologic Evidence of Hepatitis B Immunity in Children and Adolescents in the United States, 1999-2016
  Le, M., Yeo, Y. H., So, S. K., Gane, E. J., Cheung, R., & Nguyen, M. H. (2018). Prevalence of Hepatitis B Vaccination Coverage Versus Serologic Evidence of Hepatitis B Immunity in Children and Adolescents in the United States, 1999-2016. HEPATOLOGY, 68, 1192A–1193A.
- Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States.
  Han, S. S., Kelly, S. P., Li, Y., Yang, B., Nguyen, M., So, S., … Hsing, A. W. (2018). Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. Journal of the National Cancer Institute.
- Identification of prognostically-relevant signature genes differentially expressed between primary colorectal carcinoma and hepatic metastasis
  Lin, A. Y., Chua, M., Choi, Y. L., Yeh, W., Kim, Y. H., Azzi, R., … Pollack, J. R. (2007). Identification of prognostically-relevant signature genes differentially expressed between primary colorectal carcinoma and hepatic metastasis. JOURNAL OF CLINICAL ONCOLOGY, 25(18).
- Phase I/II study of PHY906/capecitabine in hepatocellular carcinoma
  Rose, M. G., Yen, Y., So, S., Saif, M. W., Chu, E., Liu, S., … Cheng, Y. (2007). Phase I/II study of PHY906/capecitabine in hepatocellular carcinoma. JOURNAL OF CLINICAL ONCOLOGY, 25(18).
- PHY906 as a broad-spectrum enhancer in cancer therapy: Clinical and preclinical results in hepatocellular carcinoma
  Liu, S.-H., Foo, A., Jiang, Z., Marathe, R., Guan, J., Su, T.-M., … Cheng, Y.-C. (2006). PHY906 as a broad-spectrum enhancer in cancer therapy: Clinical and preclinical results in hepatocellular carcinoma. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Real-time freehand 3D ultrasound system for clinical applications
  Welch, J. N., Johnson, J. A., Bax, M. R., Badr, R., So, S., Krummel, T., & Shahidi, R. (2001). Real-time freehand 3D ultrasound system for clinical applications. MEDICAL IMAGING 2001: VISUALIZATION, DISPLAY, AND IMAGE-GUIDED PROCEDURES, 4319, 724–30.
- Identification of diagnostic markers/candidate therapeutic targets for liver cancer using cDNA microarray.
  Cheung, S. T., Chen, Fan, S. T., So, S., Ng, I. O., & Brown, P. (2001). Identification of diagnostic markers/candidate therapeutic targets for liver cancer using cDNA microarray. CLINICAL CANCER RESEARCH, 7(11), 3691S.
- Proceedings of the First University of California, San Francisco-Stanford University Asia Liver Symposium - Introduction
  So, S., & Keeffe, E. B. (1999). Proceedings of the First University of California, San Francisco-Stanford University Asia Liver Symposium - Introduction. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 14, U1.
- PREVALENCE OF ANEMIA AFTER TRANSPLANTATION IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
  ALUZRI, A., LUCQ, J., SALVATIERRA, O., & CONLEY, S. (1995). PREVALENCE OF ANEMIA AFTER TRANSPLANTATION IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 1069.
- EFFECTS OF CYCLOSPORINE AND TACROLIMUS ON ACTIVATION OF KUPFFER CELLS IN-VITRO
  TOJIMBARA, T., BERMUDEZ, L., EGAWA, H., SO, S., & ESQUIVEL, C. O. (1995). EFFECTS OF CYCLOSPORINE AND TACROLIMUS ON ACTIVATION OF KUPFFER CELLS IN-VITRO. HEPATOLOGY, 22(4), 430.
- Effective hepatitis B vaccination by serologic results in the United States: a population-based study from 1999-2016
  Le, M. H., Lee, D. H., Lee, M.-H., Gane, E., So, S., & Nguyen, M. (2018). Effective hepatitis B vaccination by serologic results in the United States: a population-based study from 1999-2016. JOURNAL OF HEPATOLOGY, 68, S480.
- Suboptimal rates of effective hepatitis B vaccination in adults at high risk of infection in the United States from 1999-2014
  Le, M. H., Lee, D. H., Lee, M.-H., Gane, E., So, S., & Nguyen, M. (2018). Suboptimal rates of effective hepatitis B vaccination in adults at high risk of infection in the United States from 1999-2014. JOURNAL OF HEPATOLOGY, 68, S480–S481.
- Imaging of hepatocellular carcinoma patient-derived xenografts using (89)Zr-labeled anti-glypican-3 monoclonal antibody.
  Yang, X., Liu, H., Sun, C. K., Natarajan, A., Hu, X., Wang, X., … So, S. K. (2014). Imaging of hepatocellular carcinoma patient-derived xenografts using (89)Zr-labeled anti-glypican-3 monoclonal antibody. Biomaterials, 35(25), 6964–71.
- Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California.
  Toy, M., Wei, B., Virdi, T. S., Le, A., Trinh, H., Li, J., … Nguyen, M. H. (2018). Racial/ethnic- and county-specific prevalence of chronic hepatitis B and its burden in California. Hepatology, Medicine and Policy, 3, 6.
- Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions.
  Hutton, D. W., Brandeau, M. L., & So, S. K. (2011). Doing Good with Good OR: Supporting Cost-effective Hepatitis B Interventions. Interfaces, 41(3), 289–300.
- Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam
  Pham, T. T. H., Le, T. X., Nguyen, D. T., Luu, C. M., Truong, B. D., Tran, P. D., … So, S. (2019). Knowledge, attitudes and practices of hepatitis B prevention and immunization of pregnant women and mothers in northern Vietnam. PLOS ONE, 14(4).
- Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States
  Ispas, S., So, S., & Toy, M. (2019). Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States. JOURNAL OF COMMUNITY HEALTH, 44(3), 610–25.
- A transfer RNA derived small RNA affects translation in rapidly dividing cells and a target for hepatocellular carcinoma
  Kim, H. K., Fuchs, G., Wang, S., Wei, W., Zhang, Y., Park, H., … Kay, M. A. (2018). A transfer RNA derived small RNA affects translation in rapidly dividing cells and a target for hepatocellular carcinoma. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States
  Han, S. S., Kelly, S. P., Li, Y., Yang, B., Nguyen, M., So, S., … Hsing, A. W. (2019). Changing Landscape of Liver Cancer in California: A Glimpse Into the Future of Liver Cancer in the United States. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 111(6), 550–56.
- The Hep B Calculator: an online tool for cost-effectiveness analyses of treatment.
  Toy, M., Hutton, D. W., Lauer, J., Bulterys, M., Hutin, Y., & So, S. (2019). The Hep B Calculator: an online tool for cost-effectiveness analyses of treatment. The Lancet. Gastroenterology & Hepatology.
- Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention
  Yang, B., Liu, J. B., So, S. K., Han, S. S., Wang, S. S., Hertz, A., … Hsing, A. W. (2018). Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention. CANCER, 124(17), 3551–59.
- Management of hepatitis B infected pregnant women: a cross-sectional study of obstetricians.
  Chao, S. D., Cheung, C. M., Chang, E. T., Pei, A., & So, S. K. (2019). Management of hepatitis B infected pregnant women: a cross-sectional study of obstetricians. BMC Pregnancy and Childbirth, 19(1), 275.
- Economic Analyses to Inform and Support Health Policy for Chronic Hepatitis B Treatment
  Toy, M., Hutton, D. W., & So, S. (2019). Economic Analyses to Inform and Support Health Policy for Chronic Hepatitis B Treatment. Current Hepatology Reports.
- Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam.
  Hang Pham, T. T., Le, T. X., Nguyen, D. T., Luu, C. M., Truong, B. D., Tran, P. D., … So, S. (2019). Knowledge, attitudes and medical practice regarding hepatitis B prevention and management among healthcare workers in Northern Vietnam. PloS One, 14(10), e0223733.
- WHO ARE RECEIVING LIVER TRANSPLANTS IN THE US IN THE ERA OF DAAS?
  Wang, S., Toy, M., & So, S. K. (2019). WHO ARE RECEIVING LIVER TRANSPLANTS IN THE US IN THE ERA OF DAAS? HEPATOLOGY, 70, 922A.
- An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics.
  Gani, A. W., Wei, W., Shi, R.-Z. Z., Ng, E., Nguyen, M., Chua, M.-S. S., … Wang, S. X. (2019). An Automated, Quantitative, and Multiplexed Assay Suitable for Point-of-Care Hepatitis B Virus Diagnostics. Scientific Reports, 9(1), 15615.
- ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES PHASE ONE REPORT Introduction
  Buckley, G. J., Strom, B. L., Andrus, J. K., Aronsohn, A., Church, D., Cohen, S., … Martinez, R. M. (2016). ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES PHASE ONE REPORT Introduction. ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES: PHASE ONE REPORT, 13–31.
- ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES PHASE ONE REPORT Summary
  Buckley, G. J., Strom, B. L., Andrus, J. K., Aronsohn, A., Church, D., Cohen, S., … Martinez, R. M. (2016). ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES PHASE ONE REPORT Summary. ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES: PHASE ONE REPORT, 1-+.
- The Elimination of Hepatitis C
  Buckley, G. J., Strom, B. L., Andrus, J. K., Aronsohn, A., Church, D., Cohen, S., … Martinez, R. M. (2016). The Elimination of Hepatitis C. ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES: PHASE ONE REPORT, 83–134.
- ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES PHASE ONE REPORT Conclusion
  Buckley, G. J., Strom, B. L., Andrus, J. K., Aronsohn, A., Church, D., Cohen, S., … Martinez, R. M. (2016). ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES PHASE ONE REPORT Conclusion. ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES: PHASE ONE REPORT, 135–38.
- The Elimination of Hepatitis B
  Buckley, G. J., Strom, B. L., Andrus, J. K., Aronsohn, A., Church, D., Cohen, S., … Martinez, R. M. (2016). The Elimination of Hepatitis B. ELIMINATING THE PUBLIC HEALTH PROBLEM OF HEPATITIS B AND C IN THE UNITED STATES: PHASE ONE REPORT, 33–82.
- Population Health And Economic Impacts Of Reaching Chronic Hepatitis B Diagnosis And Treatment Targets In The US
  Toy, M., Hutton, D. W., & So, S. (2018). Population Health And Economic Impacts Of Reaching Chronic Hepatitis B Diagnosis And Treatment Targets In The US. HEALTH AFFAIRS, 37(7), 1033–40.
- ANALYSIS OF FACTORS LEADING TO LOW ACUTE REJECTION EPISODES IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
  ALUZRI, A., SO, S., SALVATIERRA, O., & CONLEY, S. (1995). ANALYSIS OF FACTORS LEADING TO LOW ACUTE REJECTION EPISODES IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 6(3), 1069.
- Hepatitis B cure: modeling the economics of a potential cost of a cure.
  Toy, M., So, S., & Hutton, D. W. (2020). Hepatitis B cure: modeling the economics of a potential cost of a cure. Current Opinion in HIV and AIDS.
- An NIR-II/MR dual modal nanoprobe for liver cancer imaging.
  Ren, Y., He, S., Huttad, L., Chua, M.-S. S., So, S. K., Guo, Q., & Cheng, Z. (2020). An NIR-II/MR dual modal nanoprobe for liver cancer imaging. Nanoscale.
- A Summary of the 2020 Gastric Cancer Summit at Stanford University.
  Huang, R. J., Koh, H., & Hwang, J. H. (2020). A Summary of the 2020 Gastric Cancer Summit at Stanford University. Gastroenterology.
- Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019.
  Wang, S., Toy, M., Hang Pham, T. T., & So, S. (2020). Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the U.S., 2010-2019. PloS One, 15(9), e0239393.
- Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016.
  Le, M. H., Yeo, Y. H., So, S., Gane, E., Cheung, R. C., & Nguyen, M. H. (2020). Prevalence of Hepatitis B Vaccination Coverage and Serologic Evidence of Immunity Among US-Born Children and Adolescents From 1999 to 2016. JAMA Network Open, 3(11), e2022388.
- Computational discovery and preclinical validation of therapeutic leads with novel MOAs for hepatocellular carcinoma and pancreatic ductal adenocarcinoma
  Hakim, I., Chua, M.-S., Wei, W., Ma, L., Noblin, E., So, S., … Heuer, T. S. (2020). Computational discovery and preclinical validation of therapeutic leads with novel MOAs for hepatocellular carcinoma and pancreatic ductal adenocarcinoma. CANCER RESEARCH. AMER ASSOC CANCER RESEARCH.
- Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
  Toy, M., Hutton, D., Harris, A. M., Nelson, N., Salomon, J. A., & So, S. (2021). Cost-Effectiveness of One-Time Universal Screening for Chronic Hepatitis B Infection in Adults in the United States. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.
- Knowledge, Attitudes and Practices toward Hepatitis B Virus Infection among Students of Medicine in Vietnam
  Nguyen, T. T. L., Pham, T. T. H., So, S., Hoang, T. H. V., Nguyen, T. T. U., Ngo, T. B., … Pham, M. K. (2021). Knowledge, Attitudes and Practices toward Hepatitis B Virus Infection among Students of Medicine in Vietnam. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 18(13).
- The Price Tag of a Potential Cure for Chronic Hepatitis B Infection: A Cost Threshold Analysis for USA, China, and Australia.
  Toy, M., Hutton, D., McCulloch, K., Romero, N., Revill, P. A., Penicaud, M.-C., … Cowie, B. C. (2021). The Price Tag of a Potential Cure for Chronic Hepatitis B Infection: A Cost Threshold Analysis for USA, China, and Australia. Liver International : Official Journal of the International Association for the Study of the Liver.
- A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts.
  Natarajan, A., Zhang, H., Ye, W., Huttad, L., Tan, M., Chua, M.-S., … So, S. K. (2021). A Humanized Anti-GPC3 Antibody for Immuno-Positron Emission Tomography Imaging of Orthotopic Mouse Model of Patient-Derived Hepatocellular Carcinoma Xenografts. Cancers, 13(16).
- NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody
  Shi, H., Huttad, L. V., Tan, M., Liu, H., Chua, M.-S., Cheng, Z., & So, S. (2021). NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody. RSC MEDICINAL CHEMISTRY.
- Letter to the Editor: Importance of Universal Screening for Chronic Hepatitis B Infection in Adults in the United States.
  Cohen, C., Moraras, K., Jackson, M., Kamischke, M., Gish, R. G., Brosgart, C. L., … So, S. (1800). Letter to the Editor: Importance of Universal Screening for Chronic Hepatitis B Infection in Adults in the United States. Hepatology (Baltimore, Md.).
- NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody.
  Shi, H., Huttad, L. V., Tan, M., Liu, H., Chua, M.-S. S., Cheng, Z., & So, S. (2022). NIR-II imaging of hepatocellular carcinoma based on a humanized anti-GPC3 antibody. RSC Medicinal Chemistry, 13(1), 90–97.
- Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections.
  Hutton, D., Toy, M., Salomon, J. A., Conners, E. E., Nelson, N. P., Harris, A. M., & So, S. (2022). Cost-Effectiveness of Hepatitis B Testing and Vaccination of Adults Seeking Care for Sexually Transmitted Infections. Sexually Transmitted Diseases.
- Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology.
  Lerner, Y., Sukumaran, S., Chua, M.-S., So, S. K., & Qvit, N. (2022). Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology. Journal of Visualized Experiments : JoVE, (181).
- Costs and health impact of delayed implementation of a national hepatitis B treatment program in China.
  Toy, M., Hutton, D., Jia, J., & So, S. (2022). Costs and health impact of delayed implementation of a national hepatitis B treatment program in China. Journal of Global Health, 12, 04043.
- Knowledge and Attitude Related to Hepatitis C among Medical Students in the Oral Direct Acting Antiviral Agents Era in Vietnam.
  Pham, T. T., Nguyen, T. T., So, S., Hoang, T. H., Nguyen, T. T., Ngo, T. B., … Pham, M. K. (2022). Knowledge and Attitude Related to Hepatitis C among Medical Students in the Oral Direct Acting Antiviral Agents Era in Vietnam. International Journal of Environmental Research and Public Health, 19(19).
- Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination.
  So, S., Terrault, N., & Conners, E. E. (2023). Universal Adult Hepatitis B Screening and Vaccination as the Path to Elimination. JAMA.
- Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019.
  Pham, T. T., Toy, M., Hutton, D., Thompson, W., Conners, E. E., Nelson, N. P., … So, S. (2023). Gaps and Disparities in Chronic Hepatitis B Monitoring and Treatment in the United States, 2016-2019. Medical Care, 61(4), 247–253.
- Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015-2020.
  Pham, T. T., Maria, N., Cheng, V., Nguyen, B., Toy, M., Hutton, D., … So, S. (2023). Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015-2020. American Journal of Preventive Medicine.
- Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma.
  Sukumaran, S., Tan, M., Ben-Uliel, S. F., Zhang, H., De Zotti, M., Chua, M.-S. S., … Qvit, N. (2023). Rational design, synthesis and structural characterization of peptides and peptidomimetics to target Hsp90/Cdc37 interaction for treating hepatocellular carcinoma. Computational and Structural Biotechnology Journal, 21, 3159–3172.
- Psychometric Tests for Hepatitis B - A Systematic Review.
  Ispas, S.-A., Iliescu, D., Ren, L., So, S., & Toy, M. (2023). Psychometric Tests for Hepatitis B - A Systematic Review. Evaluation & the Health Professions, 1632787231188458.
- Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma.
  Ahmad, F., Ma, L., Wei, W., Liu, Y., Hakim, I., Daugherty, A., … So, S. (2023). Identification and validation of microtubule depolymerizing agent, CYT997, as a potential drug candidate for hepatocellular carcinoma. Liver International : Official Journal of the International Association for the Study of the Liver.
- Authors' Response to Letter to the Editor Regarding "Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015-2020".
  Pham, T. T., & So, S. (2023). Authors' Response to Letter to the Editor Regarding "Gaps in Prenatal Hepatitis B Screening and Management of HBsAg Positive Pregnant Persons in the U.S., 2015-2020". American Journal of Preventive Medicine, 65(5), 952.
- Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice.
  Liu, Y., Guerrero, D. Q., Lechuga-Ballesteros, D., Tan, M., Ahmad, F., Aleiwi, B., … So, S. (2024). Lipid-Based Self-Microemulsion of Niclosamide Achieved Enhanced Oral Delivery and Anti-Tumor Efficacy in Orthotopic Patient-Derived Xenograft of Hepatocellular Carcinoma in Mice. International Journal of Nanomedicine, 19, 2639–2653.
- Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States.
  Hutton, D. W., Toy, M., Yang, D., Zhang, H., Handanagic, S., Armstrong, P. A., … So, S. K. (2024). Modelling the potential impact of global hepatitis B vaccination on the burden of chronic hepatitis B in the United States. Journal of Viral Hepatitis.
- Epidemiology of Chronic Hepatitis B Virus Infection, Alameda County, California, 2017-2021.
  Yette, E., Marusinec, R., Conlon, C., Pham, T. T., Toy, M., So, S., … Chitnis, A. S. (2024). Epidemiology of Chronic Hepatitis B Virus Infection, Alameda County, California, 2017-2021. Journal of Public Health Management and Practice : JPHMP.
- Feasibility and Acceptability of Universal Adult Screening for Chronic Hepatitis B in Primary Care Clinics.
  Chu, R. V., Sarnala, S., Doan, T. V., Jamal, A., Phadke, A., So, S., … Srinivasan, M. (2024). Feasibility and Acceptability of Universal Adult Screening for Chronic Hepatitis B in Primary Care Clinics. AJPM Focus, 3(6), 100240.
- Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B.
  Toy, M., Hutton, D., Conners, E. E., Pham, H., Salomon, J. A., & So, S. (2025). Cost-effectiveness of monitoring and liver cancer surveillance among patients with inactive chronic hepatitis B. PloS One, 20(1), e0313898.
- Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States.
  Toy, M., Hutton, D., Teshale, E., Thompson, W. W., Pham, H., Salomon, J. A., & So, S. (2025). Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States. Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America.

View More Publications

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

Identification of New Serum Diagnostic Markers of Hepatocellular Carcinoma

Practice Locations

,

Important Information about Our Organizations and Physician Affiliation

Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.

Patient Reviews

(12 reviews)

Dr. Samuel So was my care provider/physician. Do not let this dedicated, brilliant, caring doctor ever retire! Despite the reason why you are there, he still gives hope and common sense about your condition. It is easy to put up with the less than good staff because Dr. So is your doctor. The staff attitude (lacks professionalism, courtesy) sometimes may be generational. You don't get the sense they give 100% to the patients. They do their job.

Oct 2019

•

Verified SHC Patient

Good experience.

Apr 2018

•

Verified SHC Patient

Good experience.

Jan 2018

•

Verified SHC Patient

Good experience.

Nov 2016

•

Verified SHC Patient

Good experience.

Aug 2016

•

Verified SHC Patient

Good experience.

Apr 2016

•

Verified SHC Patient

Dr. So has been giving me excellent care for almost 9 years. Dr. saved my life.

Oct 2015

•

Verified SHC Patient

Very good experience.

Jun 2015

•

Verified SHC Patient

Good experience.

Apr 2015

•

Verified SHC Patient

Good experience.

Aug 2014

•

Verified SHC Patient

Good experience.

Mar 2014

•

Verified SHC Patient

Dr. So is one of the physicians who makes a difference in a patient's life and is truly a brilliant exceptional asset to Stanford's reputation.

Mar 2014

•

Verified SHC Patient

View More Patient Reviews

Referring Physicians

PHYSICIAN HELPLINE

Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.

Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.

You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.

Send referrals online
Place radiology and lab orders
View referral status
Access medical records

Learn More About MedLink

LOG INTO MEDLINK

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Samuel So, MD

Surgical oncologist, Liver surgeon, General surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Practice Locations

,

,

Important Information about Our Organizations and Physician Affiliation

Patient Reviews

(12 reviews)

Referring Physicians

PHYSICIAN HELPLINE

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

WELCOME BACK

Samuel So, MD

Surgical oncologist, Liver surgeon, General surgeon

Get In Touch

Biography

Professional Summary

Education & Certifications

Honors & Awards

Memberships

Administrative Appointments

Publications

Clinical Trials

Practice Locations

,

,

Important Information about Our Organizations and Physician Affiliation

Patient Reviews

(12 reviews)

Referring Physicians

PHYSICIAN HELPLINE